Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Harry Crijns

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Chemicals & Drugs

Procedures

Devices

Electrocardiography

Concepts & Ideas

Phenomena

Recurrence

Anatomy

Heart Conduction System

Activities & Behaviors

Artificial Cardiac Pacing

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
85
Van Gelder, Isabelle
65
van Veldhuisen, Dirk
45
van Gilst, Wiek
43
van den Berg, Maarten
30
Tieleman, Robert
24
de Kam, Pieter
19
Gosselink, Marcel
18
Haaksma, Jaap
18
Brouwer, Jan
18
Pinto, Yigal
17
van Boven, Ad
16
Tuinenburg, Anton
16
Grandjean, Jan
14
Honig, Adriaan
13
De Langen, CD

Sign-in to see all Coauthors

Publications

TOP 3
Groenveld Hessel F; Crijns Harry J G M; Rienstra Michiel; Van den Berg Maarten P; Van Veldhuisen Dirk J; Van Gelder Isabelle C;
Does intensity of rate control influence outcome in persistent atrial fibrillation? Data of the RACE study.
Crijns Harry J G M
Primary prevention of atrial fibrillation by statins: still unresolved?
Bour A; Rasquin S; Aben I; Strik J; Boreas A; Crijns H; Limburg M; Verhey F
The symptomatology of post-stroke depression: comparison of stroke and myocardial infarction patients.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Harry Crijns (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Groenveld Hessel F; Crijns Harry J G M; Rienstra Michiel; Van den Berg Maarten P; Van Veldhuisen Dirk J; Van Gelder Isabelle C;
Does intensity of rate control influence outcome in persistent atrial fibrillation? Data of the RACE study.
American heart journal 2009;158(5):785-91.
2009: Crijns Harry J G M
Primary prevention of atrial fibrillation by statins: still unresolved?
European heart journal 2009;30(19):2302-3.
2009: Bour A; Rasquin S; Aben I; Strik J; Boreas A; Crijns H; Limburg M; Verhey F
The symptomatology of post-stroke depression: comparison of stroke and myocardial infarction patients.
International journal of geriatric psychiatry 2009;24(10):1134-42.
2009: Pisters Ron; de Vos Cees B; Nieuwlaat Robby; Crijns Harry J G M
Use and underuse of oral anticoagulation for stroke prevention in atrial fibrillation: old and new paradigms.
Seminars in thrombosis and hemostasis 2009;35(6):554-9.
2009: Connolly Stuart J; Crijns Harry J G M; Torp-Pedersen Christian; van Eickels Martin; Gaudin Christophe; Page Richard L; Hohnloser Stefan H;
Analysis of stroke in ATHENA: a placebo-controlled, double-blind, parallel-arm trial to assess the efficacy of dronedarone 400 mg BID for the prevention of cardiovascular hospitalization or death from any cause in patients with atrial fibrillation/atrial flutter.
Circulation 2009;120(13):1174-80.
2009: de Vos Cees B; Crijns Harry J G M; Tieleman Robert G
The fibrillating atrial myocardium visualized: an unexploited source of information.
Heart rhythm : the official journal of the Heart Rhythm Society 2009;6(8):1247-8.
2009: Nieuwlaat Robby; Eurlings Luc W; Cleland John G; Cobbe Stuart M; Vardas Panos E; Capucci Alessandro; López-Sendòn José L; Meeder Joan G; Pinto Yigal M; Crijns Harry J G M
Atrial fibrillation and heart failure in cardiology practice: reciprocal impact and combined management from the perspective of atrial fibrillation: results of the Euro Heart Survey on atrial fibrillation.
Journal of the American College of Cardiology 2009;53(18):1690-8.
2009: van Kimmenade Roland R J; Januzzi James L; Bakker Jaap A; Houben Alphonse J; Rennenberg Roger; Kroon Abraham A; Crijns Harry J G M; van Dieijen-Visser Marja P; de Leeuw Peter W; Pinto Yigal M
Renal clearance of B-type natriuretic peptide and amino terminal pro-B-type natriuretic peptide a mechanistic study in hypertensive subjects.
Journal of the American College of Cardiology 2009;53(10):884-90.
2009: van Opstal Jurren M; Volders Paul G A; Crijns Harry J G M
Provocation of silence.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2009;11(3):385-7.
2009: Hohnloser Stefan H; Crijns Harry J G M; van Eickels Martin; Gaudin Christophe; Page Richard L; Torp-Pedersen Christian; Connolly Stuart J;
Effect of dronedarone on cardiovascular events in atrial fibrillation.
The New England journal of medicine 2009;360(7):668-78.
2008: Smolders Lilian; Majidi Mohamed; Krucoff Mitchell W; Crijns Harry J G M; Wellens Hein J J; Gorgels Anton P M
Preexcitation and myocardial infarction: conditions with confusing electrocardiographic manifestations.
Journal of electrocardiology 2008;41(6):679-82.
2008: Ahmed Sheba; Rienstra Michiel; Crijns Harry J G M; Links Thera P; Wiesfeld Ans C P; Hillege Hans L; Bosker Hans A; Lok Dirk J A; Van Veldhuisen Dirk J; Van Gelder Isabelle C;
Continuous vs episodic prophylactic treatment with amiodarone for the prevention of atrial fibrillation: a randomized trial.
JAMA : the journal of the American Medical Association 2008;300(15):1784-92.
2008: Nieuwlaat Robby; Prins Martin H; Le Heuzey Jean-Yves; Vardas Panos E; Aliot Etienne; Santini Massimo; Cobbe Stuart M; Widdershoven Jos W M G; Baur Leo H; Lévy Samuel; Crijns Harry J G M
Prognosis, disease progression, and treatment of atrial fibrillation patients during 1 year: follow-up of the Euro Heart Survey on atrial fibrillation.
European heart journal 2008;29(9):1181-9.
2008: Nieuwlaat Robby; Dinh Trang; Olsson S Bertil; Camm A John; Capucci Alessandro; Tieleman Robert G; Lip Gregory Y H; Crijns Harry J G M;
Should we abandon the common practice of withholding oral anticoagulation in paroxysmal atrial fibrillation?
European heart journal 2008;29(7):915-22.
2008: Ringborg Anna; Nieuwlaat Robby; Lindgren Peter; Jönsson Bengt; Fidan Dogan; Maggioni Aldo P; Lopez-Sendon Jose; Stepinska Janina; Cokkinos Dennis V; Crijns Harry J G M
Costs of atrial fibrillation in five European countries: results from the Euro Heart Survey on atrial fibrillation.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2008;10(4):403-11.
2008: de Vos Cees B; Nieuwlaat Robby; Crijns Harry J G M; Camm A John; LeHeuzey Jean-Yves; Kirchhof Charles J; Capucci Alessandro; Breithardt Günter; Vardas Panos E; Pisters Ron; Tieleman Robert G
Autonomic trigger patterns and anti-arrhythmic treatment of paroxysmal atrial fibrillation: data from the Euro Heart Survey.
European heart journal 2008;29(5):632-9.
2008: Lemmert Miguel E; de Jong Jonas S S G; van Stipdonk Antonius M W; Crijns Harry J G M; Wellens Hein J J; Krucoff Mitchell W; Dekker Lukas R; Wilde Arthur A M; Gorgels Anton P M
Electrocardiographic factors playing a role in ischemic ventricular fibrillation in ST elevation myocardial infarction are related to the culprit artery.
Heart rhythm : the official journal of the Heart Rhythm Society 2008;5(1):71-8.
2008: Hohnloser Stefan H; Connolly Stuart J; Crijns Harry J G M; Page Richard L; Seiz Werner; Torp-Petersen Christian
Rationale and design of ATHENA: A placebo-controlled, double-blind, parallel arm Trial to assess the efficacy of dronedarone 400 mg bid for the prevention of cardiovascular Hospitalization or death from any cause in patiENts with Atrial fibrillation/atrial flutter.
Journal of cardiovascular electrophysiology 2008;19(1):69-73.
2007: Blaauw Y; Crijns H J G M
Atrial fibrillation: insights from clinical trials and novel treatment options.
Journal of internal medicine 2007;262(6):593-614.
2007: Bekkers Sebastiaan C A M; Eikemans Bob J W; Tieleman Robert; Braat Simon H J G; Dassen Willem; Partouns Jean; de Zwaan Chris; Crijns Harry J G M; de Krom Marc C T F M
Hypothermia for out-of-hospital cardiac arrest survivors: a single-center experience.
The American journal of emergency medicine 2007;25(9):1078-80.
2007: Honig Adriaan; Kuyper Astrid M G; Schene Aart H; van Melle Joost P; de Jonge Peter; Tulner Dorien M; Schins Annique; Crijns Harry J G M; Kuijpers Petra M J C; Vossen Helen; Lousberg Richel; Ormel Johan;
Treatment of post-myocardial infarction depressive disorder: a randomized, placebo-controlled trial with mirtazapine.
Psychosomatic medicine 2007;69(7):606-13.
2007: Singh Bramah N; Connolly Stuart J; Crijns Harry J G M; Roy Denis; Kowey Peter R; Capucci Alessandro; Radzik David; Aliot Etienne M; Hohnloser Stefan H;
Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter.
The New England journal of medicine 2007;357(10):987-99.
2007: Vernooy Kevin; Cornelussen Richard N M; Verbeek Xander A A M; Vanagt Ward Y R; van Hunnik Arne; Kuiper Marion; Arts Theo; Crijns Harry J G M; Prinzen Frits W
Cardiac resynchronization therapy cures dyssynchronopathy in canine left bundle-branch block hearts.
European heart journal 2007;28(17):2148-55.
2007: Donker Dirk W; Maessen Jos G; Spätjens Roel L H M G; van der Nagel Theo; de Jong Monique; Ramaekers Frans C; Crijns Harry J G M; Vos Marc A; Volders Paul G A
Serial left-ventricular biopsy sampling using a minimally invasive trans-thoracic approach in adult dogs.
Pflügers Archiv : European journal of physiology 2007;454(6):1043-51.
2007: van Melle Joost P; de Jonge Peter; Honig Adriaan; Schene Aart H; Kuyper Astrid M G; Crijns Harry J G M; Schins Annique; Tulner Dorien; van den Berg Maarten P; Ormel Johan;
Effects of antidepressant treatment following myocardial infarction.
The British journal of psychiatry : the journal of mental science 2007;190():460-6.
2007: Nieuwlaat Robby; Olsson S Bertil; Lip Gregory Y H; Camm A John; Breithardt Günter; Capucci Alessandro; Meeder Joan G; Prins Martin H; Lévy Samuel; Crijns Harry J G M;
Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial Fibrillation.
American heart journal 2007;153(6):1006-12.
2007: Donker Dirk W; Maessen Jos G; Verheyen Fons; Ramaekers Frans C; Spätjens Roel L H M G; Kuijpers Helma; Ramakers Christian; Schiffers Paul M H; Vos Marc A; Crijns Harry J G M; Volders Paul G A
Impact of acute and enduring volume overload on mechanotransduction and cytoskeletal integrity of canine left ventricular myocardium.
American journal of physiology. Heart and circulatory physiology 2007;292(5):H2324-32.
2007: Kietselaer Bas L J H; Reutelingsperger Chris P M; Boersma Hendrikus H; Heidendal Guido A K; Liem Ing Han; Crijns Harry J G M; Narula Jagat; Hofstra Leo
Noninvasive detection of programmed cell loss with 99mTc-labeled annexin A5 in heart failure.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2007;48(4):562-7.
2007: Rienstra Michiel; Van Veldhuisen Dirk J; Crijns Harry J G M; Van Gelder Isabelle C;
Enhanced cardiovascular morbidity and mortality during rhythm control treatment in persistent atrial fibrillation in hypertensives: data of the RACE study.
European heart journal 2007;28(6):741-51.
2007: Dagres Nikolaos; Nieuwlaat Robby; Vardas Panos E; Andresen Dietrich; Lévy Samuel; Cobbe Stuart; Kremastinos Dimitrios Th; Breithardt Günter; Cokkinos Dennis V; Crijns Harry J G M
Gender-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Heart Survey on Atrial Fibrillation.
Journal of the American College of Cardiology 2007;49(5):572-7.
2007: Dinh T; Nieuwlaat R; Tieleman R G; Büller H R; van Charante N A Mensing; Prins M H; Crijns H J G M
Antithrombotic drug prescription in atrial fibrillation and its rationale among general practitioners, internists and cardiologists in The Netherlands--The EXAMINE-AF study. A questionnaire survey.
International journal of clinical practice 2007;61(1):24-31.
2007: Schins A; Crijns H J; Brummer R-J M; Wichers M; Lousberg R; Celis S; Honig A
Altered omega-3 polyunsaturated fatty acid status in depressed post-myocardial infarction patients.
Acta psychiatrica Scandinavica 2007;115(1):35-40.
2007: Vernooy Kevin; Verbeek Xander A A M; Cornelussen Richard N M; Dijkman Barbara; Crijns Harry J G M; Arts Theo; Prinzen Frits W
Calculation of effective VV interval facilitates optimization of AV delay and VV interval in cardiac resynchronization therapy.
Heart rhythm : the official journal of the Heart Rhythm Society 2007;4(1):75-82.
2006: Fuster Valentín; Rydén Lars E; Cannom David S; Crijns Harry J; Curtis Anne B; Ellenbogen Kenneth A; Halperin Jonathan L; Le Heuzey Jean-Yves; Neal Kay G; Lowe James E; Bertil Olsson S; Prystowsky Eric N; Tamargo Juan L; Wann Samuel
[Guidelines for the management of patients with atrial fibrillation. Executive summary]
Revista española de cardiología 2006;59(12):1329.
2006: Nieuwlaat Robby; Capucci Alessandro; Lip Gregory Y H; Olsson S Bertil; Prins Martin H; Nieman Fred H; López-Sendón José; Vardas Panos E; Aliot Etienne; Santini Massimo; Crijns Harry J G M;
Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation.
European heart journal 2006;27(24):3018-26.
2006: Crijns Harry J; Van Gelder Isabelle C; Walfridsson Håkan; Kulakowski Piotr; Rónaszéki Aladár; Dedek Vratislav; Malm Anders; Almgren Olle
Safe and effective conversion of persistent atrial fibrillation to sinus rhythm by intravenous AZD7009.
Heart rhythm : the official journal of the Heart Rhythm Society 2006;3(11):1321-31.
2006: Van Gelder Isabelle C; Wyse D George; Chandler Mary L; Cooper Howard A; Olshansky Brian; Hagens Vincent E; Crijns Harry J G M;
Does intensity of rate-control influence outcome in atrial fibrillation? An analysis of pooled data from the RACE and AFFIRM studies.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2006;8(11):935-42.
2006: Duytschaever Mattias; Heyse Alex; de Sutter Johan; Crijns Harry; Gillebert Thierry; Tavernier Rene; Tieleman Robert
Transthoracic tissue Doppler imaging of the atria: a novel method to determine the atrial fibrillation cycle length.
Journal of cardiovascular electrophysiology 2006;17(11):1202-9.
2006: Spijkerman Titia A; van den Brink Rob H S; May Jo F; Winter Jobst B; van Melle Joost P; de Jonge Peter; Crijns Harry J G M; Ormel Johan
Decreased impact of post-myocardial infarction depression on cardiac prognosis?
Journal of psychosomatic research 2006;61(4):493-9.
2006: Hagens Vincent E; Rienstra Michiel; Van Veldhuisen Dirk J; Crijns Harry J G M; Van Gelder Isabelle C
Determinants of sudden cardiac death in patients with persistent atrial fibrillation in the rate control versus electrical cardioversion (RACE) study.
The American journal of cardiology 2006;98(7):929-32.
2006: van Kimmenade Roland R; Januzzi James L; Ellinor Patrick T; Sharma Umesh C; Bakker Jaap A; Low Adrian F; Martinez Abelardo; Crijns Harry J; MacRae Calum A; Menheere Paul P; Pinto Yigal M
Utility of amino-terminal pro-brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure.
Journal of the American College of Cardiology 2006;48(6):1217-24.
2006: Hemels Martin E W; Van Noord Trudeke; Crijns Harry J G M; Van Veldhuisen Dirk J; Veeger Nic J G M; Bosker Hans A; Wiesfeld Ans C P; Van den Berg Maarten P; Ranchor Adelita V; Van Gelder Isabelle C
Verapamil versus digoxin and acute versus routine serial cardioversion for the improvement of rhythm control for persistent atrial fibrillation.
Journal of the American College of Cardiology 2006;48(5):1001-9.
2006: Vernooy Kevin; Sicouri Serge; Dumaine Robert; Hong Kui; Oliva Antonio; Burashnikov Elena; Timmermans Carl; Delhaas Tammo; Crijns Harry J G M; Antzelevitch Charles; Rodriguez Luz-Maria; Brugada Ramon
Genetic and biophysical basis for bupivacaine-induced ST segment elevation and VT/VF. Anesthesia unmasked Brugada syndrome.
Heart rhythm : the official journal of the Heart Rhythm Society 2006;3(9):1074-8.
2006: Van Gelder Isabelle C; Van Veldhuisen Dirk J; Crijns Harry J G M; Tuininga Ype S; Tijssen Jan G P; Alings A Marco; Bosker Hans A; Cornel Jan H; Kamp Otto; Veeger Nic J G M; Volbeda Meint; Rienstra Michiel; Ranchor Adelita V; TenVergert Elisabeth M; Van den Berg Maarten P
RAte Control Efficacy in permanent atrial fibrillation: a comparison between lenient versus strict rate control in patients with and without heart failure. Background, aims, and design of RACE II.
American heart journal 2006;152(3):420-6.
2006: Brundel Bianca J J M; Henning Robert H; Ke Lei; van Gelder Isabelle C; Crijns Harry J G M; Kampinga Harm H
Heat shock protein upregulation protects against pacing-induced myolysis in HL-1 atrial myocytes and in human atrial fibrillation.
Journal of molecular and cellular cardiology 2006;41(3):555-62.
2006: van Empel Vanessa P M; Bertrand Anne T; van Oort Ralph J; van der Nagel Roel; Engelen Markus; van Rijen Harold V; Doevendans Pieter A; Crijns Harry J; Ackerman Susan L; Sluiter Wim; De Windt Leon J
EUK-8, a superoxide dismutase and catalase mimetic, reduces cardiac oxidative stress and ameliorates pressure overload-induced heart failure in the harlequin mouse mutant.
Journal of the American College of Cardiology 2006;48(4):824-32.
2006: Fuster Valentin; Rydén Lars E; Cannom David S; Crijns Harry J; Curtis Anne B; Ellenbogen Kenneth A; Halperin Jonathan L; Le Heuzey Jean-Yves; Kay G Neal; Lowe James E; Olsson S Bertil; Prystowsky Eric N; Tamargo Juan Luis; Wann Samuel;
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation).
European heart journal 2006;27(16):1979-2030.
2006: Veeger N J G M; Piersma-Wichers M; Hillege H L; Crijns H J G M; van der Meer J
Early detection of patients with a poor response to vitamin K antagonists: the clinical impact of individual time within target range in patients with heart disease.
Journal of thrombosis and haemostasis : JTH 2006;4(7):1625-7.
2006: Hagens Vincent E; Van Veldhuisen Dirk J; Crijns Harry J G M; van Gelder Isabelle C
Implication from randomized trials of rate and rhythm controls on management of patients with persistent atrial fibrillation.
Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc 2006;11(2):170-86.
2006: Vernooy Kevin; Dijkman Barbara; Cheriex Emile C; Prinzen Frits W; Crijns Harry J G M
Ventricular remodeling during long-term right ventricular pacing following His bundle ablation.
The American journal of cardiology 2006;97(8):1223-7.
2006: Folkeringa R J; Hartgers J; Tieleman R G; Gorgels A P; Dassen W R M; Crijns H J G M
Atrial extrasystoles after exercise predict atrial fibrillation in patients with left ventricular hypertrophy.
Heart (British Cardiac Society) 2006;92(4):545-6.
2006: van Melle Joost P; de Jonge Peter; Kuyper Astrid M G; Honig Adriaan; Schene Aart H; Crijns Harry J G M; van den Berg Maarten P; van Veldhuisen Dirk J; Ormel Johan;
Prediction of depressive disorder following myocardial infarction data from the Myocardial INfarction and Depression-Intervention Trial (MIND-IT).
International journal of cardiology 2006;109(1):88-94.
2006: Folkeringa Richard J; Van Kraaij Dave J; Tieleman Robert G; Nieman Fred H M; Pinto Yigal M; Crijns Harry J G M
Statins associated with reduced mortality in patients admitted for congestive heart failure.
Journal of cardiac failure 2006;12(2):134-8.
2006: van Kimmenade Roland; van Dielen François; Bakker Jaap; Nijhuis Jeroen; Crijns Harry; Buurman Wim; van Dieijen-Visser Marja; Greve Jan-Willem; Pinto Yigal
Is brain natriuretic peptide production decreased in obese subjects?
Journal of the American College of Cardiology 2006;47(4):886-7.
2006: Vernooy Kevin; Delhaas Tammo; Cremer Olaf L; Di Diego José M; Oliva Antonio; Timmermans Carl; Volders Paul G; Prinzen Frits W; Crijns Harry J G M; Antzelevitch Charles; Kalkman Cornelis J; Rodriguez Luz-Maria; Brugada Ramon
Electrocardiographic changes predicting sudden death in propofol-related infusion syndrome.
Heart rhythm : the official journal of the Heart Rhythm Society 2006;3(2):131-7.
2006: Rienstra Michiel; Van Gelder Isabelle C; Hagens Vincent E; Veeger Nic J G M; Van Veldhuisen Dirk J; Crijns Harry J G M
Mending the rhythm does not improve prognosis in patients with persistent atrial fibrillation: a subanalysis of the RACE study.
European heart journal 2006;27(3):357-64.
2006: de Jonge Peter; Ormel Johan; van den Brink Rob H S; van Melle Joost P; Spijkerman Titia A; Kuijper Astrid; van Veldhuisen Dirk J; van den Berg Maarten P; Honig Adriaan; Crijns Harry J G M; Schene Aart H
Symptom dimensions of depression following myocardial infarction and their relationship with somatic health status and cardiovascular prognosis.
The American journal of psychiatry 2006;163(1):138-44.
2006: van Veldhuisen Dirk J; Crijns Harry J G M; van den Berg Maarten P
Heart failure, atrial fibrillation, and beta-blockers.
European heart journal 2006;27(2):247.
2006: Nieuwlaat R; Lenzen M; Crijns H J G M; Prins M H; Scholte op Reimer W J; Battler A; Hasdai D; Danchin N; Gitt A K; Simoons M L; Boersma E
Which factors are associated with the application of reperfusion therapy in ST-elevation acute coronary syndromes?. Lessons from the Euro Heart Survey on Acute Coronary Syndromes I.
Cardiology 2006;106(3):137-46.
2005: van Melle Joost P; de Jonge Peter; Ormel Johan; Crijns Harry J G M; van Veldhuisen Dirk J; Honig Adriaan; Schene Aart H; van den Berg Maarten P;
Relationship between left ventricular dysfunction and depression following myocardial infarction: data from the MIND-IT.
European heart journal 2005;26(24):2650-6.
2005: Schoonderwoerd Bas A; Van Gelder Isabelle C; Van Veldhuisen Dirk J; Van den Berg Maarten P; Crijns Harry J G M
Electrical and structural remodeling: role in the genesis and maintenance of atrial fibrillation.
Progress in cardiovascular diseases 2005;48(3):153-68.
2005: Spijkerman Titia; de Jonge Peter; van den Brink Rob H S; Jansen Jaap H C; May Jo F; Crijns Harry J G M; Ormel Johan
Depression following myocardial infarction: first-ever versus ongoing and recurrent episodes.
General hospital psychiatry 2005;27(6):411-7.
2005: Nieuwlaat Robby; Capucci Alessandro; Camm A John; Olsson S Bertil; Andresen Dietrich; Davies D Wyn; Cobbe Stuart; Breithardt Günter; Le Heuzey Jean-Yves; Prins Martin H; Lévy Samuel; Crijns Harry J G M;
Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation.
European heart journal 2005;26(22):2422-34.
2005: Rienstra Michiel; Van Veldhuisen Dirk J; Hagens Vincent E; Ranchor Adelita V; Veeger Nic J G M; Crijns Harry J G M; Van Gelder Isabelle C;
Gender-related differences in rhythm control treatment in persistent atrial fibrillation: data of the Rate Control Versus Electrical Cardioversion (RACE) study.
Journal of the American College of Cardiology 2005;46(7):1298-306.
2005: Van Berlo J H; Voncken J W; Kubben N; Broers J L V; Duisters R; van Leeuwen R E W; Crijns H J G M; Ramaekers F C S; Hutchison C J; Pinto Y M
A-type lamins are essential for TGF-beta1 induced PP2A to dephosphorylate transcription factors.
Human molecular genetics 2005;14(19):2839-49.
2005: Vink Roel; Rienstra Michiel; van Dongen Carlo J J; Levi Marcel; Büller Harry R; Crijns Harry J; van Gelder Isabelle C
Risk of thromboembolism and bleeding after general surgery in patients with atrial fibrillation.
The American journal of cardiology 2005;96(6):822-4.
2005: Smedema Jan-Peter; Snoep Gabriel; van Kroonenburgh Marinus P G; van Geuns Robert-Jan; Cheriex Emiel C; Gorgels Anton P M; Crijns Harry J G M
The additional value of gadolinium-enhanced MRI to standard assessment for cardiac involvement in patients with pulmonary sarcoidosis.
Chest 2005;128(3):1629-37.
2005: Merckx Klaartje L; De Vos Cees B; Palmans Andrea; Habets Jos; Cheriex Emile C; Crijns Harry J G M; Tieleman Robert G
Atrial activation time determined by transthoracic Doppler tissue imaging can be used as an estimate of the total duration of atrial electrical activation.
Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography 2005;18(9):940-4.
2005: Smedema Jan-Peter; Snoep Gabriel; van Kroonenburgh Marinus P G; van Geuns Robert-Jan; Dassen Willem R M; Gorgels Anton P; Crijns Harry J G M
Cardiac involvement in patients with pulmonary sarcoidosis assessed at two university medical centers in the Netherlands.
Chest 2005;128(1):30-5.
2005: Schins Annique; Van Kroonenburgh Marinus; Van Laere Koen; D'haenen Hugo; Lousberg Richel; Crijns Harry; Eersels Jos; Honig Adriaan
Increased cerebral serotonin-2A receptor binding in depressed patients with myocardial infarction.
Psychiatry research 2005;139(2):155-63.
2005: van Empel Vanessa P M; Bertrand Anne T A; Hofstra Leo; Crijns Harry J; Doevendans Pieter A; De Windt Leon J
Myocyte apoptosis in heart failure.
Cardiovascular research 2005;67(1):21-9.
2005: Donker D W; Volders P G A; Arts T; Bekkers B C A M; Hofstra L; Spätjens R L H M G; Beekman J D M; Borgers M; Crijns H J G M; Vos M A
End-diastolic myofiber stress and ejection strain increase with ventricular volume overload--Serial in-vivo analyses in dogs with complete atrioventricular block.
Basic research in cardiology 2005;100(4):372-82.
2005: Hagens Vincent E; Crijns Harry J G M; Van Veldhuisen Dirk J; Van Den Berg Maarten P; Rienstra Michiel; Ranchor Adelita V; Bosker Hans A; Kamp Otto; Tijssen Jan G P; Veeger Nic J G M; Van Gelder Isabelle C;
Rate control versus rhythm control for patients with persistent atrial fibrillation with mild to moderate heart failure: results from the RAte Control versus Electrical cardioversion (RACE) study.
American heart journal 2005;149(6):1106-11.
2005: van Empel Vanessa P M; Bertrand Anne T; van der Nagel Roel; Kostin Sawa; Doevendans Pieter A; Crijns Harry J; de Wit Elly; Sluiter Wim; Ackerman Susan L; De Windt Leon J
Downregulation of apoptosis-inducing factor in harlequin mutant mice sensitizes the myocardium to oxidative stress-related cell death and pressure overload-induced decompensation.
Circulation research 2005;96(12):e92-e101.
2005: Spijkerman Titia A; van den Brink Rob H S; Jansen Jaap H C; Crijns Harry J G M; Ormel Johan
Who is at risk of post-MI depressive symptoms?
Journal of psychosomatic research 2005;58(5):425-32; discussion 433-4.
2005: Smedema J P; van Erven L; Schreur J H M; Dijkman-Domanska B; Snoep G; Crijns H J G M
[Cardiac sarcoidosis: improved prognosis through new diagnostic tests and treatment]
Nederlands tijdschrift voor geneeskunde 2005;149(21):1168-73.
2005: Smedema Jan-Peter; Snoep Gabriel; van Kroonenburgh Marinus P G; van Geuns Robert-Jan; Dassen Willem R M; Gorgels Anton P M; Crijns Harry J G M
Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis.
Journal of the American College of Cardiology 2005;45(10):1683-90.
2005: Bekkers Sebastiaan C A M; Habets Jos H M; Cheriex E C; Palmans Andrea; Pinto Yigal; Hofstra Leo; Crijns Harry J G M
Abdominal aortic aneurysm screening during transthoracic echocardiography in an unselected population.
Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography 2005;18(5):389-93.
2005: Tieleman Robert G; Van Gelder Isabelle C; Bosker Hans A; Kingma Tsjerk; Wilde Arthur A M; Kirchhof Charles J H J; Bennekers Johan H; Bracke Frank A L E; Veeger Nic J G M; Haaksma Jaap; Allessie Maurits A; Crijns Harry J G M
Does flecainide regain its antiarrhythmic activity after electrical cardioversion of persistent atrial fibrillation?
Heart rhythm : the official journal of the Heart Rhythm Society 2005;2(3):223-30.
2005: Schins Annique; Tulner Dorien; Lousberg Richel; Kenis Gunter; Delanghe Joris; Crijns Harry J; Grauls Gert; Stassen Frank; Maes Michael; Honig Adriaan;
Inflammatory markers in depressed post-myocardial infarction patients.
Journal of psychiatric research 2005;39(2):137-44.
2005: Hagens Vincent E; Van Veldhuisen Dirk J; Kamp Otto; Rienstra Michiel; Bosker Hans A; Veeger Nic J G M; Tijssen Jan G P; Crijns Harry J G M; Van Gelder Isabelle C;
Effect of rate and rhythm control on left ventricular function and cardiac dimensions in patients with persistent atrial fibrillation: results from the RAte Control versus Electrical Cardioversion for Persistent Atrial Fibrillation (RACE) study.
Heart rhythm : the official journal of the Heart Rhythm Society 2005;2(1):19-24.
2005: Neven Kars G E J; Crijns Harry J G M; Cheriex Emile C
Late left ventricular pseudoaneurysm formation following subacute myocardial infarction.
International journal of cardiology 2005;98(1):165-7.
2005: Nabar A; Timmermans C; Medeiros A; Polymeropoulos K; Crijns H J G M; Rodriguez L M
Radiofrequency ablation of atrial arrhythmias after previous open-heart surgery.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2005;7(1):40-9.
2005: Vernooy Kevin; Verbeek Xander A A M; Peschar Maaike; Crijns Harry J G M; Arts Theo; Cornelussen Richard N M; Prinzen Frits W
Left bundle branch block induces ventricular remodelling and functional septal hypoperfusion.
European heart journal 2005;26(1):91-8.
2005: van Berlo Jop H; de Voogt Willem G; van der Kooi Anneke J; van Tintelen J Peter; Bonne Gisèle; Yaou Rabah Ben; Duboc Denis; Rossenbacker Tom; Heidbüchel Hein; de Visser Marianne; Crijns Harry J G M; Pinto Yigal M
Meta-analysis of clinical characteristics of 299 carriers of LMNA gene mutations: do lamin A/C mutations portend a high risk of sudden death?
Journal of molecular medicine (Berlin, Germany) 2005;83(1):79-83.
2005: Crijns Harry J G M
Rate versus rhythm control in patients with atrial fibrillation: what the trials really say.
Drugs 2005;65(12):1651-67.
2005: Van Noord Trudeke; Crijns Harry J G M; van den Berg Maarten P; Van Veldhuisen Dirk J; Van Gelder Isabelle C
Pretreatment with ACE inhibitors improves acute outcome of electrical cardioversion in patients with persistent atrial fibrillation.
BMC cardiovascular disorders 2005;5(1):3.
2004: Smedema Jan P; Winckels Stephan K G; Snoep Gabriel; Vainer Jindra; Bekkers Sebastiaan C A M; Crijns Harry J G M
Tropical endomyocardial fibrosis (Davies' disease): case report demonstrating the role of magnetic resonance imaging.
The international journal of cardiovascular imaging 2004;20(6):517-22.
2004: Rienstra Michiel; Hagens Vincent E; Van Veldhuisen Dirk J; Bosker Hans A; Tijssen Jan G P; Kamp Otto; Bouma Jelte; Veeger Nic J G M; Crijns Harry J G M; Van Gelder Isabelle C;
Clinical characteristics of persistent lone atrial fibrillation in the RACE study.
The American journal of cardiology 2004;94(12):1486-90.
2004: Schins Annique; Hamulyák Karly; Scharpé Simon; Lousberg Richel; Van Melle Joost; Crijns Harry; Honig Adriaan
Whole blood serotonin and platelet activation in depressed post-myocardial infarction patients.
Life sciences 2004;76(6):637-50.
2004: Manusama Randy; Timmermans Carl; Philippens Suzanne; Crijns Harry J G M; Ayers Gregory M; Rodriguez Luz-Maria
Single cryothermia applications of less than five minutes produce permanent cavotricuspid isthmus block in humans.
Heart rhythm : the official journal of the Heart Rhythm Society 2004;1(5):594-9.
2004: Sharma Umesh C; Pokharel Saraswati; van Brakel Thomas J; van Berlo Jop H; Cleutjens Jack P M; Schroen Blanche; André Sabine; Crijns Harry J G M; Gabius Hans-J; Maessen Jos; Pinto Yigal M
Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction.
Circulation 2004;110(19):3121-8.
2004: Pokharel Saraswati; van Geel Peter P; Sharma Umesh C; Cleutjens Jack P M; Bohnemeier Holger; Tian Xiao-Li; Schunkert Heribert; Crijns Harry J G M; Paul Martin; Pinto Yigal M
Increased myocardial collagen content in transgenic rats overexpressing cardiac angiotensin-converting enzyme is related to enhanced breakdown of N-acetyl-Ser-Asp-Lys-Pro and increased phosphorylation of Smad2/3.
Circulation 2004;110(19):3129-35.
2004: Folkeringa Richard J; Tieleman Robert G; Crijns Harry J G M
Non-antiarrhythmic drugs to prevent atrial fibrillation.
Heart rhythm : the official journal of the Heart Rhythm Society 2004;1(4):516-8.
2004: Schoonderwoerd Bas A; Ausma Jannie; Crijns Harry J G M; Van Veldhuisen Dirk J; Blaauw Engbert H; Van Gelder Isabelle C
Atrial ultrastructural changes during experimental atrial tachycardia depend on high ventricular rate.
Journal of cardiovascular electrophysiology 2004;15(10):1167-74.
2004: Van Den Berg Maarten P; Van Noord Trudeke; Brouwer Jan; Haaksma Jaap; Van Veldhuisen Dirk J; Crijns Harry J G M; Van Gelder Isabelle C
Clustering of RR intervals predicts effective electrical cardioversion for atrial fibrillation.
Journal of cardiovascular electrophysiology 2004;15(9):1027-33.
2004: Hagens Vincent E; Vermeulen Karin M; TenVergert Elisabeth M; Van Veldhuisen Dirk J; Bosker Hans A; Kamp Otto; Kingma J Herre; Tijssen Jan G P; Crijns Harry J G M; Van Gelder Isabelle C;
Rate control is more cost-effective than rhythm control for patients with persistent atrial fibrillation--results from the RAte Control versus Electrical cardioversion (RACE) study.
European heart journal 2004;25(17):1542-9.
2004: Schroen Blanche; Heymans Stephane; Sharma Umesh; Blankesteijn W Matthijs; Pokharel Saraswati; Cleutjens Jack P M; Porter J Gordon; Evelo Chris T A; Duisters Rudy; van Leeuwen Rick E W; Janssen Ben J A; Debets Jacques J M; Smits Jos F M; Daemen Mat J A P; Crijns Harry J G M; Bornstein Paul; Pinto Yigal M
Thrombospondin-2 is essential for myocardial matrix integrity: increased expression identifies failure-prone cardiac hypertrophy.
Circulation research 2004;95(5):515-22.
2004: Crijns H J G M
[What is the anticoagulant guideline after ablation due to atrial fibrillation?]
Nederlands tijdschrift voor geneeskunde 2004;148(35):1746.
2004: Schoonderwoerd Bas A; Crijns Harry J G M; van Veldhuisen Dirk J; Boomsma Frans; van den Berg Maarten P; Bel Klaas J; van Gelder Isabelle C
Atrial natriuretic peptides during experimental atrial tachycardia: role of developing tachycardiomyopathy.
Journal of cardiovascular electrophysiology 2004;15(8):927-32.
2004: Strik Jacqueline J M H; Lousberg Richel; Crijns Harry J G M; Maes Michael; Honig Adriaan
Reply to a reader's comment.
The American journal of cardiology 2004;94(4):542.
2004: Dinh N H Trang; Crijns Harry J G M
Stroke and bleeding as an endpoint in atrial fibrillation studies.
Heart rhythm : the official journal of the Heart Rhythm Society 2004;1(2 Suppl):B27-30.
2004: Crijns H J G M
[The practice guideline 'atrial fibrillation' from the Dutch College of General Practitioners; a response from the perspective of cardiology]
Nederlands tijdschrift voor geneeskunde 2004;148(29):1425-6.
2004: Terpstra Willem F; May Johan F; Smit Andries J; Graeff Pieter Ade; Meyboom-de Jong Betty; Crijns Harry J G M
Effects of amlodipine and lisinopril on intima-media thickness in previously untreated, elderly hypertensive patients (the ELVERA trial).
Journal of hypertension 2004;22(7):1309-16.
2004: Van Noord Trudeke; Tieleman Robert G; Bosker Hans A; Kingma Tsjerk; Van Veldhuisen Dirk J; Crijns Harry J G M; Van Gelder Isabelle C
Beta-blockers prevent subacute recurrences of persistent atrial fibrillation only in patients with hypertension.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2004;6(4):343-50.
2004: Merckx K L; Tieleman R G; Crijns H J G M
Cardioversion threshold, IRAF and beyond.
European heart journal 2004;25(11):997.
2004: Tuinenburg Anton E; Van Gelder Isabelle C; Van Den Berg Maarten P; Grandjean Jan G; Tieleman Robert G; Smit Andries J; Huet Rolf C G; Van Der Maaten Joost M A A; Volkers Corine P; Ebels Tjark; Crijns Harry J G M
Sinus node function after cardiac surgery: is impairment specific for the maze procedure?
International journal of cardiology 2004;95(1):101-8.
2004: Folkeringa Richard J; Pinto Yigal M; Crijns Harry J G M
Aldosterone levels after angiotensin receptor blocker treatment.
Circulation 2004;109(14):e182; author reply e182.
2004: Manusama Randy; Timmermans Carl; Limon Froylan; Philippens Suzanne; Crijns Harry J G M; Rodriguez Luz-Maria
Catheter-based cryoablation permanently cures patients with common atrial flutter.
Circulation 2004;109(13):1636-9.
2004: Wijffels Maurits C E F; Crijns Harry J G M
Rate versus rhythm control in atrial fibrillation.
Cardiology clinics 2004;22(1):63-9.
2004: Wiesfeld A C P; Tan E S; Van Veldhuisen D J; Crijns H J G M; Van Gelder I C
Radiofrequency ablation of atrial fibrillation.
International journal of cardiology 2004;93(2-3):231-7.
2004: van Rooij Eva; Doevendans Pieter A; Crijns Harry J G M; Heeneman Sylvia; Lips Daniel J; van Bilsen Marc; Williams R Sanders; Olson Eric N; Bassel-Duby Rhonda; Rothermel Beverly A; De Windt Leon J
MCIP1 overexpression suppresses left ventricular remodeling and sustains cardiac function after myocardial infarction.
Circulation research 2004;94(3):e18-26.
2004: Hagens Vincent E; Ranchor Adelita V; Van Sonderen Eric; Bosker Hans A; Kamp Otto; Tijssen Jan G P; Kingma J Herre; Crijns Harry J G M; Van Gelder Isabelle C;
Effect of rate or rhythm control on quality of life in persistent atrial fibrillation. Results from the Rate Control Versus Electrical Cardioversion (RACE) Study.
Journal of the American College of Cardiology 2004;43(2):241-7.
2004: Folkeringa Johan R; Crijns H J G M; Van Veldhuisen D J
Prognosis of atrial fibrillation in congestive heart failure.
Circulation 2004;109(2):e11.
2004: Smedema J P; van Paassen P; van Kroonenburgh M J P G; Snoep G; Crijns H J G M; Tervaert J W Cohen
Cardiac involvement of Churg Strauss syndrome demonstrated by magnetic resonance imaging.
Clinical and experimental rheumatology 2004;22(6 Suppl 36):S75-8.
2003: Folkeringa Richard J; Dinh Trang N H; Crijns Harry J G M
Oral anticoagulation and stroke in atrial fibrillation.
The New England journal of medicine 2003;349(24):2360-1; author reply 2360-1.
2003: Timmermans Carl; Rodriguez Luz-Maria; Crijns Harry J G M; Moorman Antoon F M; Wellens Hein J J
Idiopathic left bundle-branch block-shaped ventricular tachycardia may originate above the pulmonary valve.
Circulation 2003;108(16):1960-7.
2003: Schins Annique; Honig Adriaan; Crijns Harrie; Baur Leo; Hamulyák Karly
Increased coronary events in depressed cardiovascular patients: 5-HT2A receptor as missing link?
Psychosomatic medicine 2003;65(5):729-37.
2003: Wijffels Maurits C E F; Crijns Harry J G M
Recent advances in drug therapy for atrial fibrillation.
Journal of cardiovascular electrophysiology 2003;14(9 Suppl):S40-7.
2003: Tse Hung-Fat; Reek Sven; Timmermans Carl; Lee Kathy Lai-Fun; Geller J Christoph; Rodriguez Luz-Maria; Ghaye Benoit; Ayers Gregory M; Crijns Harry J G M; Klein Helmut U; Lau Chu-Pak
Pulmonary vein isolation using transvenous catheter cryoablation for treatment of atrial fibrillation without risk of pulmonary vein stenosis.
Journal of the American College of Cardiology 2003;42(4):752-8.
2003: Touboul Paul; Brugada Josep; Capucci Alessandro; Crijns Harry J G M; Edvardsson Nils; Hohnloser Stefan H
Dronedarone for prevention of atrial fibrillation: a dose-ranging study.
European heart journal 2003;24(16):1481-7.
2003: Kuijpers Petra M J C; Denollet Johan; Lousberg Richel; Wellens Hein J J; Crijns Harry; Honig Adriaan
Validity of the hospital anxiety and depression scale for use with patients with noncardiac chest pain.
Psychosomatics 2003;44(4):329-35.
2003: Hagens Vincent E; Van Gelder Isabelle C; Crijns Harry J G M;
The RACE study in perspective of randomized studies on management of persistent atrial fibrillation.
Cardiac electrophysiology review 2003;7(2):118-21.
2003: Terpstra Willem F; May Johan F; Smit Andries J; de Graeff Pieter A; Crijns Harry J G M
Effects of nifedipine on carotid and femoral arterial wall thickness in previously untreated hypertensive patients.
Blood pressure. Supplement 2003;1():22-9.
2003: Lévy Samuel; Camm A John; Saksena Sanjeev; Aliot Etienne; Breithardt Gunter; Crijns Harry J G M; Davies D Wyn; Kay G Neal; Prystowsky Eric N; Sutton Richard; Waldo Albert L; Wyse D George;
International consensus on nomenclature and classification of atrial fibrillation: A collaborative project of the Working Group on Arrhythmias and the Working Group of Cardiac Pacing of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology.
Journal of cardiovascular electrophysiology 2003;14(4):443-5.
2003: Neven Kars; Crijns Harry; Gorgels Anton
Atrial infarction: a neglected electrocardiographic sign with important clinical implications.
Journal of cardiovascular electrophysiology 2003;14(3):306-8.
2003: Timmermans Carl; Ayers Gregory M; Crijns Harry J G M; Rodriguez Luz-Maria
Randomized study comparing radiofrequency ablation with cryoablation for the treatment of atrial flutter with emphasis on pain perception.
Circulation 2003;107(9):1250-2.
2003: van den Berg M P; Hassink R J; Baljé-Volkers C; Crijns H J G M
Role of the autonomic nervous system in vagal atrial fibrillation.
Heart (British Cardiac Society) 2003;89(3):333-5.
2002: Strik Jacqueline J M H; Lousberg Richel; Crijns Harry J G M; Maes Michael; Honig Adriaan
Relation of levels of serum lipoproteins to depression after acute myocardial infarction.
The American journal of cardiology 2002;90(12):1368-70.
2002: Van Gelder Isabelle C; Hagens Vincent E; Bosker Hans A; Kingma J Herre; Kamp Otto; Kingma Tsjerk; Said Salah A; Darmanata Julius I; Timmermans Alphons J M; Tijssen Jan G P; Crijns Harry J G M;
A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation.
The New England journal of medicine 2002;347(23):1834-40.
2002: Rodriguez Luz-Maria; Geller J Christoph; Tse Hung-Fat; Timmermans Carl; Reek Sven; Lee Kathy Lai-fun; Ayers Gregory M; Lau Chu-Pak; Klein Helmut U; Crijns Harry J G M
Acute results of transvenous cryoablation of supraventricular tachycardia (atrial fibrillation, atrial flutter, Wolff-Parkinson-White syndrome, atrioventricular nodal reentry tachycardia).
Journal of cardiovascular electrophysiology 2002;13(11):1082-9.
2002: Timmermans Carl; Rodriguez Luz-Maria; Van Suylen Robert Jan; Leunissen Jet; Vos Marc; Ayers Gregory M; Crijns Harry J G M; Wellens Hein J J
Catheter-based cryoablation produces permanent bidirectional cavotricuspid isthmus conduction block in dogs.
Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing 2002;7(2):149-55.
2002: Diercks Gilles F H; Hillege Hans L; van Boven Ad J; Kors Jan A; Crijns Harry J G M; Grobbee Diederick E; de Jong Paul E; van Gilst Wiek H
Microalbuminuria modifies the mortality risk associated with electrocardiographic ST-T segment changes.
Journal of the American College of Cardiology 2002;40(8):1401.
2002: Blaauw Y; Van Gelder I C; Crijns H J G M
Treatment of atrial fibrillation.
Heart (British Cardiac Society) 2002;88(4):432-7.
2002: Wijffels Maurits C E F; Crijns Harry J G M
Non-invasive characteristics of atrial fibrillation: the value of Holter recordings for the treatment of AF.
Cardiac electrophysiology review 2002;6(3):233-8.
2002: Van Noord Trudeke; Van Gelder Isabelle C; Crijns Harry J G M
How to enhance acute outcome of electrical cardioversion by drug therapy: importance of immediate reinitiation of atrial fibrillation.
Journal of cardiovascular electrophysiology 2002;13(8):822-5.
2002: van den Brink Rob H S; van Melle Joost P; Honig Adriaan; Schene Aart H; Crijns Harry J G M; Lambert Frank P G; Ormel Johan
Treatment of depression after myocardial infarction and the effects on cardiac prognosis and quality of life: rationale and outline of the Myocardial INfarction and Depression-Intervention Trial (MIND-IT).
American heart journal 2002;144(2):219-25.
2002: Houltz Birgitta; Darpö Börje; Crijns Harry J G M; Swedberg Karl; Blomström Per; Jensen Steen M; Svernhage Elisabeth; Edvardsson Nils
QRS aberration during atrial fibrillation at rest and during exercise. Effect of a selective potassium channel blocking agent.
Journal of electrocardiology 2002;35(3):201-12.
2002: van den Heuvel Ad F M; Bax Jeroen J; Blanksma Paul K; Vaalburg Willem; Crijns Harry J G M; van Veldhuisen Dirk J
Abnormalities in myocardial contractility, metabolism and perfusion reserve in non-stenotic coronary segments in heart failure patients.
Cardiovascular research 2002;55(1):97-103.
2002: Diercks Gilles F H; Stroes Erik S G; van Boven Ad J; van Roon Arie M; Hillege Hans L; de Jong P E; Smit Andries J; Gans Rijk O B; Crijns Harry J G M; Rabelink Ton J; van Gilst Wiek H
Urinary albumin excretion is related to cardiovascular risk indicators, not to flow-mediated vasodilation, in apparently healthy subjects.
Atherosclerosis 2002;163(1):121-6.
2002: van den Berg Maarten P; Tjeerdsma Geert; Jan de Kam Pieter; Boomsma Frans; Crijns Harry J G M; van Veldhuisen Dirk J
Longstanding atrial fibrillation causes depletion of atrial natriuretic peptide in patients with advanced congestive heart failure.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2002;4(3):255-62.
2002: Brundel Bianca J J M; Ausma Jannie; van Gelder Isabelle C; Van der Want Johan J L; van Gilst Wiek H; Crijns Harry J G M; Henning Robert H
Activation of proteolysis by calpains and structural changes in human paroxysmal and persistent atrial fibrillation.
Cardiovascular research 2002;54(2):380-9.
2002: Brundel Bianca J J M; Henning Robert H; Kampinga Harm H; Van Gelder Isabelle C; Crijns Harry J G M
Molecular mechanisms of remodeling in human atrial fibrillation.
Cardiovascular research 2002;54(2):315-24.
2002: Diercks Gilles F H; Stroes Erik S G; Van Boven Ad J; Van Roon Arie M; Hillege Hans L; De Jong Paul E; Smit Andries J; Gans Rijk O B; Crijns Harry J G M; Rabelink Ton J; Van Gilst Wiek H
Difference in the relation between urinary albumin excretion and carotid intima-media thickness in nondiabetic and type 2 diabetic subjects.
Diabetes care 2002;25(5):936-7.
2002: Muntinga H J; van den Berg F; Niemeyer M G; Blanksma P K; van der Wall E E; Crijns H J G M
Left ventricular diastolic function after electrical cardioversion of atrial fibrillation.
Heart (British Cardiac Society) 2002;87(4):379-80.
2002: de Boer Rudolf A; van Geel Peter P; Pinto Yigal M; Suurmeijer Albert J H; Crijns Harry J G M; van Gilst Wiek H; van Veldhuisen Dirk J
Efficacy of angiotensin II type 1 receptor blockade on reperfusion-induced arrhythmias and mortality early after myocardial infarction is increased in transgenic rats with cardiac angiotensin II type 1 overexpression.
Journal of cardiovascular pharmacology 2002;39(4):610-9.
2002: Schoonderwoerd Bas A; Van Gelder Isabelle C; Tieleman Robert G; Bel Klaas J; Crijns Harry J G M
Rapid pacing results in changes in atrial but not in ventricular refractoriness.
Pacing and clinical electrophysiology : PACE 2002;25(3):287-90.
2002: Timmermans Carl; Rodriguez Luz-Maria; Medeiros Argelia; Crijns Harry J G M; Wellens Hein J J
Radiofrequency catheter ablation of idiopathic ventricular tachycardia originating in the main stem of the pulmonary artery.
Journal of cardiovascular electrophysiology 2002;13(3):281-4.
2002: Middel Berrie; de Greef Mathieu; de Jongste Mike J L; Crijns Harry J G M; Stewart Roy; van den Heuvel Wim J A
Why don't we ask patients with coronary heart disease directly how much they have changed after treatment?
Journal of cardiopulmonary rehabilitation 2002;22(1):47-52.
2002: Monnink Stefan H J; van Haelst Paul L; van Boven Ad J; Stroes Erik S G; Tio René A; Plokker Thijs W M; Smit Andries J; Veeger Nic J G M; Crijns Harry J G M; van Gilst Wiek H
Endothelial dysfunction in patients with coronary artery disease: a comparison of three frequently reported tests.
Journal of investigative medicine : the official publication of the American Federation for Clinical Research 2002;50(1):19-24.
2002: Terpstra W F; May J F; Smit A J; de Graeff P A; Crijns H J G M
Microalbuminuria is related to marked end organ damage in previously untreated, elderly hypertensive patients.
Blood pressure 2002;11(2):84-90.
2001: Schoonderwoerd B A; Van Gelder I C; van Veldhuisen D J; Tieleman R G; Grandjean J G; Bel K J; Allessie M A; Crijns H J
Electrical remodeling and atrial dilation during atrial tachycardia are influenced by ventricular rate: role of developing tachycardiomyopathy.
Journal of cardiovascular electrophysiology 2001;12(12):1404-10.
2001: van den Berg M P; Hassink R J; Tuinenburg A E; Lefrandt J D; de Kam P J; Crijns H J
Impaired autonomic function predicts dizziness at onset of paroxysmal atrial fibrillation.
International journal of cardiology 2001;81(2-3):175-80.
2001: van den Heuvel A F; Blanksma P K; Siebelink H M; van Wijk L M; Boomsma F; Vaalburg W; Crijns H J; van Veldhuisen D J
Impairment of myocardial blood flow reserve in patients with asymptomatic left ventricular dysfunction: effects of ACE-inhibition with perindopril.
The international journal of cardiovascular imaging 2001;17(5):353-9.
2001: Fuster V; Rydén L E; Asinger R W; Cannom D S; Crijns H J; Frye R L; Halperin J L; Kay G N; Klein W W; Lévy S; McNamara R L; Prystowsky E N; Wann L S; Wyse D G;
ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology.
European heart journal 2001;22(20):1852-923.
2001: Middel B; Bouma J; de Jongste M; van Sonderen E; Niemeijer M G; Crijns H; van den Heuvel W
Psychometric properties of the Minnesota Living with Heart Failure Questionnaire (MLHF-Q).
Clinical rehabilitation 2001;15(5):489-500.
2001: Diercks G F; Hillege H L; van Boven A J; Kors J A; Janssen W M; Grobbee D E; Crijns H J; van Gilst W H
Relation between albumin in the urine and electrocardiographic markers of myocardial ischemia in patients without diabetes mellitus.
The American journal of cardiology 2001;88(7):771-4.
2001: Crijns H J; van Noord T; van Gelder I C
Recurrence of atrial fibrillation and the need for new definitions.
European heart journal 2001;22(19):1769-71.
2001: Van Noord T; Van Gelder I C; Crijns H J
Pericardioversion dofetilide does not suppress immediate and subacute recurrences of persistent atrial fibrillation.
Circulation 2001;104(11):E57.
2001: de Jong R M; Cornel J H; Crijns H J; van Veldhuisen D J
Abnormal contractile responses during dobutamine stress echocardiography in patients with idiopathic dilated cardiomyopathy.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2001;3(4):429-36.
2001: Van Noord T; Van Gelder I C; Tieleman R G; Bosker H A; Tuinenburg A E; Volkers C; Veeger N J; Crijns H J
VERDICT: the Verapamil versus Digoxin Cardioversion Trial: A randomized study on the role of calcium lowering for maintenance of sinus rhythm after cardioversion of persistent atrial fibrillation.
Journal of cardiovascular electrophysiology 2001;12(7):766-9.
2001: Brundel B J; Van Gelder I C; Tuinenburg A E; Wietses M; Van Veldhuisen D J; Van Gilst W H; Crijns H J; Henning R H
Endothelin system in human persistent and paroxysmal atrial fibrillation.
Journal of cardiovascular electrophysiology 2001;12(7):737-42.
2001: Hillege H L; Janssen W M; Bak A A; Diercks G F; Grobbee D E; Crijns H J; Van Gilst W H; De Zeeuw D; De Jong P E;
Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity.
Journal of internal medicine 2001;249(6):519-26.
2001: van den Berg M P; Wilde A A; Viersma TJW; Brouwer J; Haaksma J; van der Hout A H; Stolte-Dijkstra I; Bezzina TCR; Van Langen I M; Beaufort-Krol G C; Cornel J H; Crijns H J
Possible bradycardic mode of death and successful pacemaker treatment in a large family with features of long QT syndrome type 3 and Brugada syndrome.
Journal of cardiovascular electrophysiology 2001;12(6):630-6.
2001: Amoroso G; van Boven A J; Volkers C; Crijns H J; van Oeveren W
Multilink stent promotes less platelet and leukocyte adhesion than a traditional stainless steel stent: an in vitro experimental study.
Journal of investigative medicine : the official publication of the American Federation for Clinical Research 2001;49(3):265-72.
2001: Terpstra W F; May J F; Smit A J; de Graeff P A; Schuurman F H; Meyboom-de Jong B; Crijns H J
Silent ST depression and cardiovascular end-organ damage in newly found, older hypertensives.
Hypertension 2001;37(4):1083-8.
2001: Vos M A; Crijns H J
Myocardial repolarization and drugs. Impossibility to predict the dominance of anti-arrhythmic over pro-arrhythmic effects of drugs due to differential and ventricular electrical remodeling.
Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology 2001;1(1):27-34.
2001: Brundel B J; Van Gelder I C; Henning R H; Tuinenburg A E; Wietses M; Grandjean J G; Wilde A A; Van Gilst W H; Crijns H J
Alterations in potassium channel gene expression in atria of patients with persistent and paroxysmal atrial fibrillation: differential regulation of protein and mRNA levels for K+ channels.
Journal of the American College of Cardiology 2001;37(3):926-32.
2001: van Haelst P L; Timmer J R; Crijns H J; Kauffman H F; Gans R O; van Doormaal J J
No long-lasting or intermittent mast cell activation in acute coronary syndromes.
International journal of cardiology 2001;78(1):75-80.
2001: de Boer R A; Henning R H; Suurmeijer A J; Pinto Y M; Olthof E; Kirkels J H; van Gilst W H; Crijns H J; van Veldhuisen D J
Early expression of natriuretic peptides and SERCA in mild heart failure: association with severity of the disease.
International journal of cardiology 2001;78(1):5-12.
2001: Oosterga M; Voors A A; Pinto Y M; Buikema H; Grandjean J G; Kingma J H; Crijns H J; van Gilst W H
Effects of quinapril on clinical outcome after coronary artery bypass grafting (The QUO VADIS Study). QUinapril on Vascular Ace and Determinants of Ischemia.
The American journal of cardiology 2001;87(5):542-6.
2001: Terpstra W F; May J F; Smit A J; de Graeff P A; Havinga T K; van den Veur E; Schuurman F H; Meyboom-de Jong B; Crijns H J
Long-term effects of amlodipine and lisinopril on left ventricular mass and diastolic function in elderly, previously untreated hypertensive patients: the ELVERA trial.
Journal of hypertension 2001;19(2):303-9.
2001: van den Berg M P; Hassink R J; Tuinenburg A E; van Sonderen E F; Lefrandt J D; de Kam P J; van Gelder I C; Smit A J; Sanderman R; Crijns H J
Quality of life in patients with paroxysmal atrial fibrillation and its predictors: importance of the autonomic nervous system.
European heart journal 2001;22(3):247-53.
2001: Brundel B J; Van Gelder I C; Henning R H; Tieleman R G; Tuinenburg A E; Wietses M; Grandjean J G; Van Gilst W H; Crijns H J
Ion channel remodeling is related to intraoperative atrial effective refractory periods in patients with paroxysmal and persistent atrial fibrillation.
Circulation 2001;103(5):684-90.
2001: Tjeerdsma G; Szabó B M; van Wijk L M; Brouwer J; Tio R A; Crijns H J; van Veldhuisen D J
Autonomic dysfunction in patients with mild heart failure and coronary artery disease and the effects of add-on beta-blockade.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2001;3(1):33-9.
2001: Siebelink H M; Blanksma P K; Crijns H J; Bax J J; van Boven A J; Kingma T; Piers D A; Pruim J; Jager P L; Vaalburg W; van der Wall E E
No difference in cardiac event-free survival between positron emission tomography-guided and single-photon emission computed tomography-guided patient management: a prospective, randomized comparison of patients with suspicion of jeopardized myocardium.
Journal of the American College of Cardiology 2001;37(1):81-8.
2000: de Kam P J; Voors A A; van den Berg M P; van Veldhuisen D J; Brouwer J; Crijns H J; Borghi C; Ambrosioni E; Hochman J S; LeJemtel T H; Kingma J H; Sutton M S; van Gilst W H
Effect of very early angiotensin-converting enzyme inhibition on left ventricular dilation after myocardial infarction in patients receiving thrombolysis: results of a meta-analysis of 845 patients. FAMIS, CAPTIN and CATS Investigators.
Journal of the American College of Cardiology 2000;36(7):2047-53.
2000: Van Noord T; Van Gelder I C; Schoonderwoerd B A; Crijns H J
Immediate reinitiation of atrial fibrillation after electrical cardioversion predicts subsequent pharmacologic and electrical conversion to sinus rhythm and amiodarone.
The American journal of cardiology 2000;86(12):1384-5, A5.
2000: Diercks G F; van Boven A J; Hillege H L; Janssen W M; Kors J A; de Jong P E; Grobbee D E; Crijns H J; van Gilst W H
Microalbuminuria is independently associated with ischaemic electrocardiographic abnormalities in a large non-diabetic population. The PREVEND (Prevention of REnal and Vascular ENdstage Disease) study.
European heart journal 2000;21(23):1922-7.
2000: Tuinenburg A E; Van Gelder I C; Tieleman R G; Grandjean J G; Huet R C; van der Maaten J M; Pieper E G; De Kam P J; Ebels T; Crijns H J
Mini-maze suffices as adjunct to mitral valve surgery in patients with preoperative atrial fibrillation.
Journal of cardiovascular electrophysiology 2000;11(9):960-7.
2000: Diercks G F; Janssen W M; van Boven A J; Bak A A; de Jong P E; Crijns H J; van Gilst W H
Rationale, design, and baseline characteristics of a trial of prevention of cardiovascular and renal disease with fosinopril and pravastatin in nonhypertensive, nonhypercholesterolemic subjects with microalbuminuria (the Prevention of REnal and Vascular ENdstage Disease Intervention Trial [PREVEND IT]).
The American journal of cardiology 2000;86(6):635-8.
2000: Buikema H; Monnink S H; Tio R A; Crijns H J; de Zeeuw D; van Gilst W H
Comparison of zofenopril and lisinopril to study the role of the sulfhydryl-group in improvement of endothelial dysfunction with ACE-inhibitors in experimental heart failure.
British journal of pharmacology 2000;130(8):1999-2007.
2000: Crijns H J; Tjeerdsma G; de Kam P J; Boomsma F; van Gelder I C; van den Berg M P; van Veldhuisen D J
Prognostic value of the presence and development of atrial fibrillation in patients with advanced chronic heart failure.
European heart journal 2000;21(15):1238-45.
2000: Amoroso G; Tio R A; Mariani M A; Van Boven A J; Jessurun G A; Monnink S H; Grandjean J G; Boonstra P W; Crijns H J
Functional integrity and aging of the left internal thoracic artery after coronary artery bypass surgery.
The Journal of thoracic and cardiovascular surgery 2000;120(2):313-8.
2000: Nieuwland W; Berkhuysen M A; van Veldhuisen D J; Brügemann J; Landsman M L; van Sonderen E; Lie K I; Crijns H J; Rispens P
Differential effects of high-frequency versus low-frequency exercise training in rehabilitation of patients with coronary artery disease.
Journal of the American College of Cardiology 2000;36(1):202-7.
2000: Bergstra A; van Dijk R B; Brekke O; Buurma A E; Orozco L; den Heijer P; Crijns H J
Hemodynamic effects of iodixanol and iohexol during ventriculography in patients with compromised left ventricular function.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2000;50(3):314-21.
2000: Tuininga Y S; Wiesfeld A C; van Veldhuisen D J; van Gelder I C; Crijns H J
Electrophysiological changes of angiotensin-converting enzyme inhibition after myocardial infarction.
Journal of cardiac failure 2000;6(2):77-9.
2000: Tjeerdsma G; Brouwer J; de Kam P J; Haaksma J; Crijns H J; van Veldhuisen D J
Effect of mibefradil on heart rate variability in patients with chronic heart failure.
International journal of cardiology 2000;73(1):55-60.
2000: van Geel P P; Pinto Y M; Voors A A; Buikema H; Oosterga M; Crijns H J; van Gilst W H
Angiotensin II type 1 receptor A1166C gene polymorphism is associated with an increased response to angiotensin II in human arteries.
Hypertension 2000;35(3):717-21.
2000: Oosterga M; Voors A A; Buikema H; Pinto Y M; Haber H E; Ebels T; Morshuis W J; Kingma J H; Crijns H J; van Gilst W H
Angiotensin II formation in human vasculature after chronic ACE inhibition: a prospective, randomized, placebo-controlled study. QUO VADIS Investigators.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2000;14(1):55-60.
2000: Anthonio R L; van Veldhuisen D J; Breekland A; Crijns H J; van Gilst W H
Beta-blocker titration failure is independent of severity of heart failure.
The American journal of cardiology 2000;85(4):509-12, A11.
2000: Houltz B; Darpö B; Swedberg K; Blomström P; Crijns H J; Jensen S M; Svernhage E; Edvardsson N
Comparison of QT dispersion during atrial fibrillation and sinus rhythm in the same patients, at normal and prolonged ventricular repolarization.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2000;2(1):20-31.
2000: Anthonio R L; Brodde O E; van Veldhuisen D J; Scholtens E; Crijns H J; van Gilst W H
Beta-adrenoceptor density in chronic infarcted myocardium: a subtype specific decrease of beta1-adrenoceptor density.
International journal of cardiology 2000;72(2):137-41.
2000: van den Heuvel A F; van Veldhuisen D J; van der Wall E E; Blanksma P K; Siebelink H M; Vaalburg W M; van Gilst W H; Crijns H J
Regional myocardial blood flow reserve impairment and metabolic changes suggesting myocardial ischemia in patients with idiopathic dilated cardiomyopathy.
Journal of the American College of Cardiology 2000;35(1):19-28.
1999: Blaauw Y; Tieleman R G; Brouwer J; Van Den Berg; De Kam P J; De Langen C D; Haaksma J; Grandjean J G; Patberg K W; Van Gelder I C; Crijns H J
Tachycardia induced electrical remodeling of the atria and the autonomic nervous system in goats.
Pacing and clinical electrophysiology : PACE 1999;22(11):1656-67.
1999: Van Gelder I C; Tuinenburg A E; Schoonderwoerd B S; Tieleman R G; Crijns H J
Pharmacologic versus direct-current electrical cardioversion of atrial flutter and fibrillation.
The American journal of cardiology 1999;84(9A):147R-151R.
1999: Muntinga H J; Gosselink A T; Blanksma P K; De Kam P J; Van Der Wall E E; Crijns H J
Left ventricular beat to beat performance in atrial fibrillation: dependence on contractility, preload, and afterload.
Heart (British Cardiac Society) 1999;82(5):575-80.
1999: van Den Berg M P; Nagelkerke D; Brouwer R M; Mulder H; de Boer H; Crijns H J
Feasibility of pacemaker therapy after dynamic cardiomyoplasty.
Pacing and clinical electrophysiology : PACE 1999;22(10):1543-6.
1999: Jessurun G A; DeJongste M J; Hautvast R W; Tio R A; Brouwer J; van Lelieveld S; Crijns H J
Clinical follow-up after cessation of chronic electrical neuromodulation in patients with severe coronary artery disease: a prospective randomized controlled study on putative involvement of sympathetic activity.
Pacing and clinical electrophysiology : PACE 1999;22(10):1432-9.
1999: Tieleman R G; Blaauw Y; Van Gelder I C; De Langen C D; de Kam P J; Grandjean J G; Patberg K W; Bel K J; Allessie M A; Crijns H J
Digoxin delays recovery from tachycardia-induced electrical remodeling of the atria.
Circulation 1999;100(17):1836-42.
1999: Tuinenburg A E; Van Gelder I C; Van Den Berg M P; Brügemann J; De Kam P J; Crijns H J
Lack of prevention of heart failure by serial electrical cardioversion in patients with persistent atrial fibrillation.
Heart (British Cardiac Society) 1999;82(4):486-93.
1999: Jessurun G A; Hautvast R W; DeJongste M J; Meyler W J; van Boven AJ; Crijns H J
Electrical neuromodulation for disabling angina pectoris related to isolated stenoses of small epicardial coronary arteries.
The Journal of invasive cardiology 1999;11(7):435-8.
1999: Houltz B; Darpö B; Swedberg K; Blomström P; Brachmann J; Crijns H J; Jensen S M; Svernhage E; Vallin H; Edvardsson N
Effects of the Ikr-blocker almokalant and predictors of conversion of chronic atrial tachyarrhythmias to sinus rhythm. A prospective study.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 1999;13(4):329-38.
1999: Monnink S H; van Boven A J; Peels H O; Tigchelaar I; de Kam P J; Crijns H J; van Oeveren W
Silicon-carbide coated coronary stents have low platelet and leukocyte adhesion during platelet activation.
Journal of investigative medicine : the official publication of the American Federation for Clinical Research 1999;47(6):304-10.
1999: Tuinenburg A E; Brundel B J; Van Gelder I C; Henning R H; Van Den Berg M P; Driessen C; Grandjean J G; Van Gilst W H; Crijns H J
Gene expression of the natriuretic peptide system in atrial tissue of patients with paroxysmal and persistent atrial fibrillation.
Journal of cardiovascular electrophysiology 1999;10(6):827-35.
1999: Brundel B J; van Gelder I C; Henning R H; Tuinenburg A E; Deelman L E; Tieleman R G; Grandjean J G; van Gilst W H; Crijns H J
Gene expression of proteins influencing the calcium homeostasis in patients with persistent and paroxysmal atrial fibrillation.
Cardiovascular research 1999;42(2):443-54.
1999: van Veldhuisen D J; Charlesworth A; Crijns H J; Lie K I; Hampton J R
Differences in drug treatment of chronic heart failure between European countries.
European heart journal 1999;20(9):666-72.
1999: Van Gelder I C; Brundel B J; Henning R H; Tuinenburg A E; Tieleman R G; Deelman L; Grandjean J G; De Kam P J; Van Gilst W H; Crijns H J
Alterations in gene expression of proteins involved in the calcium handling in patients with atrial fibrillation.
Journal of cardiovascular electrophysiology 1999;10(4):552-60.
1999: Anthonio R L; Brouwer J; Lechat P; Haaksma J; van der Ven L; van Veldhuisen D J; Crijns H J; van Gilst W H
Different effects of bisoprolol on heart rate in patients with ischemic or idiopathic dilated cardiomyopathy (a 24-hour Holter substudy of the Cardiac Insufficiency Bisoprolol Study [CIBIS]).
The American journal of cardiology 1999;83(8):1286-9, A10.
1999: de Jong R M; Rhodes C G; Anthonio R L; Willemsen A T; Blanksma P K; Lammertsma A A; Rosen S D; Vaalburg W; Crijns H J; Camici P G
Parametric polar maps of regional myocardial beta-adrenoceptor density.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1999;40(4):507-12.
1999: Tjeerdsma G; Meinardi M T; van Der Graaf W T; van Den Berg M P; Mulder N H; Crijns H J; de Vries E G; van Veldhuisen D J
Early detection of anthracycline induced cardiotoxicity in asymptomatic patients with normal left ventricular systolic function: autonomic versus echocardiographic variables.
Heart (British Cardiac Society) 1999;81(4):419-23.
1999: Tse H F; Lau C P; Sra J S; Crijns H J; Edvardsson N; Kacet S; Wyse D G
Atrial fibrillation detection and R-wave synchronization by Metrix implantable atrial defibrillator: implications for long-term efficacy and safety. The Metrix Investigators.
Circulation 1999;99(11):1446-51.
1999: Schoonderwoerd B A; Van Gelder I C; Crijns H J
Left ventricular ischemia due to coronary stenosis as an unexpected treatable cause of paroxysmal atrial fibrillation.
Journal of cardiovascular electrophysiology 1999;10(2):224-8.
1999: van Oeveren W; Crijns H J; Korteling B J; Wegereef E W; Haan J; Tigchelaar I; Hoekstra A
Blood damage, platelet and clotting activation during application of radiofrequency or cryoablation catheters: a comparative in vitro study.
Journal of medical engineering & technology 1999;23(1):20-5.
1998: Hoekstra A; de Langen C D; Nikkels P G; Korteling B J; Bel K J; Crijns H J
Prediction of lesion size through monitoring the 0 degree C isothermic period following transcatheter cryoablation.
Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing 1998;2(4):383-9.
1998: van Veldhuisen D J; Genth-Zotz S; Brouwer J; Boomsma F; Netzer T; Man In 'T Veld A J; Pinto Y M; Lie K I; Crijns H J
High- versus low-dose ACE inhibition in chronic heart failure: a double-blind, placebo-controlled study of imidapril.
Journal of the American College of Cardiology 1998;32(7):1811-8.
1998: Jessurun G A; Tio R A; De Jongste M J; Hautvast R W; Den Heijer P; Crijns H J
Coronary blood flow dynamics during transcutaneous electrical nerve stimulation for stable angina pectoris associated with severe narrowing of one major coronary artery.
The American journal of cardiology 1998;82(8):921-6.
1998: van Veldhuisen D J; Boomsma F; de Kam P J; Man in't Veld A J; Crijns H J; Hampton J R; Lie K I
Influence of age on neurohormonal activation and prognosis in patients with chronic heart failure.
European heart journal 1998;19(5):753-60.
1998: Tuinenburg A E; Van Veldhuisen D J; Boomsma F; Van Den Berg M P; De Kam P J; Crijns H J
Comparison of plasma neurohormones in congestive heart failure patients with atrial fibrillation versus patients with sinus rhythm.
The American journal of cardiology 1998;81(10):1207-10.
1998: Oosterga M; Anthonio R L; de Kam P J; Kingma J H; Crijns H J; van Gilst W H
Effects of aspirin on angiotensin-converting enzyme inhibition and left ventricular dilation one year after acute myocardial infarction.
The American journal of cardiology 1998;81(10):1178-81.
1998: Houltz B; Darpö B; Edvardsson N; Blomström P; Brachmann J; Crijns H J; Jensen S M; Svernhage E; Vallin H; Swedberg K
Electrocardiographic and clinical predictors of torsades de pointes induced by almokalant infusion in patients with chronic atrial fibrillation or flutter: a prospective study.
Pacing and clinical electrophysiology : PACE 1998;21(5):1044-57.
1998: van Boven A J; Jukema J W; Haaksma J; Zwinderman A H; Crijns H J; Lie K I
Depressed heart rate variability is associated with events in patients with stable coronary artery disease and preserved left ventricular function. REGRESS Study Group.
American heart journal 1998;135(4):571-6.
1998: Van Gelder I C; Brügemann J; Crijns H J
Current treatment recommendations in antiarrhythmic therapy.
Drugs 1998;55(3):331-46.
1998: Van Den Berg M P; Crijns H J; Van Veldhuisen D J; Van Gelder I C; De Kam P J; Lie K I
Atrial natriuretic peptide in patients with heart failure and chronic atrial fibrillation: role of duration of atrial fibrillation.
American heart journal 1998;135(2 Pt 1):242-4.
1998: van den Berg M P; Tuinenburg A E; van Veldhuisen D J; de Kam P J; Crijns H J
Cardioversion of atrial fibrillation in the setting of mild to moderate heart failure.
International journal of cardiology 1998;63(1):63-70.
1998: Tieleman R G; Van Gelder I C; Crijns H J; De Kam P J; Van Den Berg M P; Haaksma J; Van Der Woude H J; Allessie M A
Early recurrences of atrial fibrillation after electrical cardioversion: a result of fibrillation-induced electrical remodeling of the atria?
Journal of the American College of Cardiology 1998;31(1):167-73.
1998: van Veldhuisen D J; van den Heuvel A F; Blanksma P K; Crijns H J
Ischemia and left ventricular dysfunction: a reciprocal relation?
Journal of cardiovascular pharmacology 1998;32 Suppl 1():S46-51.
1997: de Vries R J; van Veldhuisen D J; Dunselman P H; van der Veer N; Crijns H J
Physiological parameters during the initial stages of cardiopulmonary exercise testing in patients with chronic heart failure. Their value in the assessment of clinical severity and prognosis.
European heart journal 1997;18(12):1921-30.
1997: van den Berg M P; van de Ven L L; Witting W; Crijns H J; Haaksma J; Bel K J; de Langen C D; Lie K I
Effects of beta-blockade on atrial and atrioventricular nodal refractoriness, and atrial fibrillatory rate during atrial fibrillation in pigs.
Japanese heart journal 1997;38(6):841-8.
1997: Van Gelder I C; Crijns H J
Cardioversion of atrial fibrillation and subsequent maintenance of sinus rhythm.
Pacing and clinical electrophysiology : PACE 1997;20(10 Pt 2):2675-83.
1997: Mariani M A; Boonstra P W; Grandjean J G; Peels J O; Monnink S H; den Heijer P; Crijns H J
Minimally invasive coronary artery bypass grafting versus coronary angioplasty for isolated type C stenosis of the left anterior descending artery.
The Journal of thoracic and cardiovascular surgery 1997;114(3):434-9.
1997: van den Berg M P; Haaksma J; Brouwer J; Tieleman R G; Mulder G; Crijns H J
Heart rate variability in patients with atrial fibrillation is related to vagal tone.
Circulation 1997;96(4):1209-16.
1997: Gosselink A T; van den Berg M P; Crijns H J
Acute pericarditis presenting with sinus bradycardia: a case report.
International journal of cardiology 1997;60(3):307-10.
1997: Van Gelder I C; Brügemann J; Crijns H J
Pharmacological management of arrhythmias in the elderly.
Drugs & aging 1997;11(2):96-110.
1997: Gosselink A T; van Veldhuisen D J; Crijns H J
When, and when not, to use digoxin in the elderly.
Drugs & aging 1997;10(6):411-20.
1997: Crijns H J; Van den Berg M P; Van Gelder I C; Van Veldhuisen D J
Management of atrial fibrillation in the setting of heart failure.
European heart journal 1997;18 Suppl C():C45-9.
1997: Van den Berg M P; Tuinenburg A E; Crijns H J; Van Gelder I C; Gosselink A T; Lie K I
Heart failure and atrial fibrillation: current concepts and controversies.
Heart (British Cardiac Society) 1997;77(4):309-13.
1997: Tieleman R G; De Langen C; Van Gelder I C; de Kam P J; Grandjean J; Bel K J; Wijffels M C; Allessie M A; Crijns H J
Verapamil reduces tachycardia-induced electrical remodeling of the atria.
Circulation 1997;95(7):1945-53.
1997: Szabó B M; van Veldhuisen D J; van der Veer N; Brouwer J; De Graeff P A; Crijns H J
Prognostic value of heart rate variability in chronic congestive heart failure secondary to idiopathic or ischemic dilated cardiomyopathy.
The American journal of cardiology 1997;79(7):978-80.
1997: Tio R A; Van Gelder I C; Boonstra P W; Crijns H J
Myocardial bridging in a survivor of sudden cardiac near-death: role of intracoronary doppler flow measurements and angiography during dobutamine stress in the clinical evaluation.
Heart (British Cardiac Society) 1997;77(3):280-2.
1997: Crijns H J; Van Gelder I C; Tieleman R G; Brügemann J; De Kam P J; Gosselink A T; Bink-Boelkens M T; Lie K I
Long-term outcome of electrical cardioversion in patients with chronic atrial flutter.
Heart (British Cardiac Society) 1997;77(1):56-61.
1997: Breekland A; Blanksma P K; Kengen R A; Pieper E G; Crijns H J; Visser C A
Categorization of abnormal left ventricular function: comparison between radionuclide angiographic and echocardiographic technique in postinfarction patients.
The American journal of cardiology 1997;79(1):108-11.
1997: Tieleman R G; Gosselink A T; Crijns H J; van Gelder I C; van den Berg M P; de Kam P J; van Gilst W H; Lie K I
Efficacy, safety, and determinants of conversion of atrial fibrillation and flutter with oral amiodarone.
The American journal of cardiology 1997;79(1):53-7.
1996: Van Gelder I C; Crijns H J; Tieleman R G; Brügemann J; De Kam P J; Gosselink A T; Verheugt F W; Lie K I
Chronic atrial fibrillation. Success of serial cardioversion therapy and safety of oral anticoagulation.
Archives of internal medicine 1996;156(22):2585-92.
1996: Crijns H J; Van Gelder I C; Van der Woude H J; Grandjean J G; Tieleman R G; Brügemann J; De Kam P J; Ebels T
Efficacy of serial electrical cardioversion therapy in patients with chronic atrial fibrillation after valve replacement and implications for surgery to cure atrial fibrillation.
The American journal of cardiology 1996;78(10):1140-4.
1996: Pieper E P; Hamer H P; Sluijs R A; Ravelli A C; Tijssen J G; Crijns H J; Lie K I; Visser C A
Usefulness of multiplane transesophageal echocardiography to improve the assessment of severity of mitral regurgitation.
The American journal of cardiology 1996;78(10):1132-9.
1996: Posma J L; Blanksma P K; Van Der Wall E E; Vaalburg W; Crijns H J; Lie K I
Effects of permanent dual chamber pacing on myocardial perfusion in symptomatic hypertrophic cardiomyopathy.
Heart (British Cardiac Society) 1996;76(4):358-62.
1996: Jessurun G A; Tio R A; Ribbert L S; Willemse F; Boonstra P W; Crijns H J
Unusual cause of sudden cardiac death: basophilic degeneration of coronary arteries.
Catheterization and cardiovascular diagnosis 1996;39(2):172-6.
1996: van Boven A J; Jukema J W; Zwinderman A H; Crijns H J; Lie K I; Bruschke A V
Reduction of transient myocardial ischemia with pravastatin in addition to the conventional treatment in patients with angina pectoris. REGRESS Study Group.
Circulation 1996;94(7):1503-5.
1996: Wiesfeld A C; Crijns H J; Tuininga Y S; Lie K I
Beta adrenergic blockade in the treatment of sustained ventricular tachycardia or ventricular fibrillation.
Pacing and clinical electrophysiology : PACE 1996;19(7):1026-35.
1996: Gosselink A T; Smit A J; Crijns H J; Hillege H H; Lie K I
Alteration of peripheral vasodilatory reserve capacity after cardioversion of atrial fibrillation.
European heart journal 1996;17(6):926-34.
1996: Peels H O; van Boven A J; den Heijer P; Tio R A; Lie K I; Crijns H J
Deep seating of six French guiding catheters for delivery of new Palmaz-Schatz stents.
Catheterization and cardiovascular diagnosis 1996;38(2):210-3.
1996: Crijns H J; Gosselink A T; Lie K I
Propafenone versus disopyramide for maintenance of sinus rhythm after electrical cardioversion of chronic atrial fibrillation: a randomized, double-blind study. PRODIS Study Group.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 1996;10(2):145-52.
1996: Tuininga Y S; De Langen C D; Crijns H J; Wiesfeld A C; Mook P H; Bel K J; Lie K I
Electrophysiological, rate dependent, and autonomic effects of the class III antiarrhythmic almokalant after myocardial infarction in the pig.
Pacing and clinical electrophysiology : PACE 1996;19(5):802-10.
1996: Wiesfeld A C; De Langen C D; Crijns H J; Bel K J; Hillege H L; Wesseling H; Lie K I
Rate-dependent effects of the class III antiarrhythmic drug almokalant on refractoriness in the pig.
Journal of cardiovascular pharmacology 1996;27(4):594-600.
1996: van Boven A J; Brügemann J; de Graeff P A; May J F; Crijns H J
The 4S study. Implications for prescribing.
Drugs 1996;51(4):507-14.
1996: de Muinck E D; den Heijer P; van Dijk R B; Crijns H J; Hillige H L; Lie K I
Distal coronary hemoperfusion during percutaneous transluminal coronary angioplasty.
Catheterization and cardiovascular diagnosis 1996;37(3):233-40; discussion 241-2.
1996: Wiesfeld A C; Crijns H J; Van den Broek S A; Landsman M L; Hillege H L; van Gilst W H; Lie K I
Angiographic left ventricular wall motion score to predict arrhythmia recurrence in patients with sustained ventricular tachycardia or fibrillation.
Coronary artery disease 1996;7(3):225-30.
1996: Jessurun G A; Crijns H J; van Wijngaarden J
An unusual case of cardiac tamponade following electrical cardioversion.
International journal of cardiology 1996;53(3):317-20.
1995: van den Berg M P; Haaksma J; Brouwer J; Crijns H J; Lie K I
Analysis of heart rate variability in a patient with paroxysmal atrial fibrillation.
European heart journal 1995;16(12):2011-2.
1995: Tuininga Y S; Crijns H J; Brouwer J; van den Berg M P; Man in't Veld A J; Mulder G; Lie K I
Evaluation of importance of central effects of atenolol and metoprolol measured by heart rate variability during mental performance tasks, physical exercise, and daily life in stable postinfarct patients.
Circulation 1995;92(12):3415-23.
1995: Meeder J G; Blanksma P K; Crijns H J; Anthonio R L; Pruim J; Brouwer J; de Jong R M; van der Wall E E; Vaalburg W; Lie K I
Mechanisms of angina pectoris in syndrome X assessed by myocardial perfusion dynamics and heart rate variability.
European heart journal 1995;16(11):1571-7.
1995: Gosselink A T; Blanksma P K; Crijns H J; Van Gelder I C; de Kam P J; Hillege H L; Niemeijer M G; Lie K I; Meijler F L
Left ventricular beat-to-beat performance in atrial fibrillation: contribution of Frank-Starling mechanism after short rather than long RR intervals.
Journal of the American College of Cardiology 1995;26(6):1516-21.
1995: van Boven A J; Jukema J W; Crijns H J; Lie K I
Heart rate variability profiles in symptomatic coronary artery disease and preserved left ventricular function: relation to ventricular tachycardia and transient myocardial ischemia. Regression Growth Evaluation Statin Study (REGRESS).
American heart journal 1995;130(5):1020-5.
1995: van den Berg M P; Crijns H J; Bouwmeester T R; Smit A J; Lie K I
Cardiac asystole post-exercise: a report of two cases.
International journal of cardiology 1995;51(3):296-300.
1995: Crijns H J; Wiesfeld A C; Posma J L; Lie K I
Favourable outcome in idiopathic ventricular fibrillation with treatment aimed at prevention of high sympathetic tone and suppression of inducible arrhythmias.
British heart journal 1995;74(4):408-12.
1995: Szabó B M; Crijns H J; Wiesfeld A C; van Veldhuisen D J; Hillege H L; Lie K I
Predictors of mortality in patients with sustained ventricular tachycardias or ventricular fibrillation and depressed left ventricular function: importance of beta-blockade.
American heart journal 1995;130(2):281-6.
1995: van den Berg M P; de Langen C D; Haaksma J; Bel K J; Crijns H J; Dijk W A; Lie K I
Analysis of randomness of atrial and ventricular rhythm in atrial fibrillation.
European heart journal 1995;16(7):971-6.
1995: Wiesfeld A C; Crijns H J; Hillege H L; Tuininga Y S; Lie K L
The clinical significance of coronary anatomy in post-infarct patients with late sustained ventricular tachycardia or ventricular fibrillation.
European heart journal 1995;16(6):818-24.
1995: Crijns H J; Smeets J L; Rodriguez L M; Meijer A; Wellens H J
Cure of interfascicular reentrant ventricular tachycardia by ablation of the anterior fascicle of the left bundle branch.
Journal of cardiovascular electrophysiology 1995;6(6):486-92.
1995: van den Berg M P; Crijns H J; Szabó B M; Brouwer J; Lie K I
Effect of exercise on cycle length in atrial flutter.
British heart journal 1995;73(3):263-4.
1995: van Boven A J; Brouwer J; Crijns H J; Haaksma J; Lie K I
Differential autonomic mechanisms underlying early morning and daytime transient myocardial ischaemia in patients with stable coronary artery disease.
British heart journal 1995;73(2):134-8.
1995: Tieleman R G; Crijns H J; Wiesfeld A C; Posma J; Hamer H P; Lie K I
Increased dispersion of refractoriness in the absence of QT prolongation in patients with mitral valve prolapse and ventricular arrhythmias.
British heart journal 1995;73(1):37-40.
1995: Tuininga Y S; van Veldhuisen D J; Crijns H J; van den Broek S A; Brouwer J; Haaksma J; Man in 't Veld A J; Lie K I
Exploratory study of the effects of single doses of isomazole on hemodynamics and heart rate variability parameters in chronic heart failure.
Journal of cardiovascular pharmacology 1995;25(1):81-6.
1994: Tuininga Y S; van Veldhuisen D J; Brouwer J; Haaksma J; Crijns H J; Man in't Veld A J; Lie K I
Heart rate variability in left ventricular dysfunction and heart failure: effects and implications of drug treatment.
British heart journal 1994;72(6):509-13.
1994: de Muinck E D; den Heijer P; van Dijk R B; Crijns H J; Hillege H J; Twisk S P; Lie K I
Autoperfusion balloon versus stent for acute or threatened closure during percutaneous transluminal coronary angioplasty.
The American journal of cardiology 1994;74(10):1002-5.
1994: Crijns H J; Van Gelder I C; Kingma J H; Dunselman P H; Gosselink A T; Lie K I
Atrial flutter can be terminated by a class III antiarrhythmic drug but not by a class IC drug.
European heart journal 1994;15(10):1403-8.
1994: Gosselink A T; Bijlsma E B; Landsman M L; Crijns H J; Lie K I
Long-term effect of cardioversion on peak oxygen consumption in chronic atrial fibrillation. A 2-year follow-up.
European heart journal 1994;15(10):1368-72.
1994: Tobé T J; de Langen C D; Crijns H J; Wiesfeld A C; van Gilst W H; Faber K G; Lie K I; Wesseling H
Late potentials, QTc prolongation, and prediction of arrhythmic events after myocardial infarction.
International journal of cardiology 1994;46(2):121-8.
1994: Gosselink A T; Crijns H J; van den Berg M P; van den Broek S A; Hillege H; Landsman M L; Lie K I
Functional capacity before and after cardioversion of atrial fibrillation: a controlled study.
British heart journal 1994;72(2):161-6.
1994: Szabó B M; van Veldhuisen D J; Crijns H J; Wiesfeld A C; Hillege H L; Lie K I
Value of ambulatory electrocardiographic monitoring to identify increased risk of sudden death in patients with left ventricular dysfunction and heart failure.
European heart journal 1994;15(7):928-33.
1994: van Gelder I C; Crijns H J; Gosselink A T; Lie K I
[Current viewpoints in therapy and prognosis of chronic atrial fibrillation]
Nederlands tijdschrift voor geneeskunde 1994;138(20):1002-8.
1994: Wiesfeld A C; Crijns H J; Van Dijk R B; Schoots C J; Elema J D; Tuininga Y S; Lie K I
Potential role of endomyocardial biopsy in the clinical characterization of patients with idiopathic ventricular fibrillation: arrhythmogenic right ventricular dysplasia--an undervalued cause.
American heart journal 1994;127(5):1421-4.
1994: van den Berg M P; Crijns H J; Haaksma J; Brouwer J; Lie K I
Analysis of vagal effects on ventricular rhythm in patients with atrial fibrillation.
Clinical science (London, England : 1979) 1994;86(5):531-5.
1994: van den Berg M P; de Langen C D; Crijns H J; Haaksma J; Bel K J; Wesseling H; Lie K I
Effect of metoprolol on atrial fibrillatory rate, atrioventricular nodal concealed conduction, and ventricular response during atrial fibrillation in pigs.
Journal of cardiovascular pharmacology 1994;23(5):846-51.
1994: Crijns H J; van Gelder I C; Lie K I
Benefits and risks of antiarrhythmic drug therapy after DC electrical cardioversion of atrial fibrillation or flutter.
European heart journal 1994;15 Suppl A():17-21.
1994: Tuininga Y S; Crijns H J; Oosterhuis B; Wiesfeld A C; van Wijk L M; Albronda F; de Bruin H; Jonkman J H; Kozma C; Lie K I
Hemodynamic effects of the new antiarrhythmic agent restacorin in patients with normal and decreased left ventricular function.
Journal of cardiovascular pharmacology 1994;23(3):408-14.
1993: Gosselink A T; Crijns H J; Hamer H P; Hillege H; Lie K I
Changes in left and right atrial size after cardioversion of atrial fibrillation: role of mitral valve disease.
Journal of the American College of Cardiology 1993;22(6):1666-72.
1993: Wiesfeld A C; Crijns H J; Bergstrand R H; Almgren O; Hillege H L; Lie K I
Torsades de pointes with Almokalant, a new class III antiarrhythmic drug.
American heart journal 1993;126(4):1008-11.
1993: Van Gelder I C; Crijns H J; Blanksma P K; Landsman M L; Posma J L; Van Den Berg M P; Meijler F L; Lie K I
Time course of hemodynamic changes and improvement of exercise tolerance after cardioversion of chronic atrial fibrillation unassociated with cardiac valve disease.
The American journal of cardiology 1993;72(7):560-6.
1993: Tobé T J; de Langen C D; Crijns H J; Wiesfeld A C; van Gilst W H; Faber K G; Lie K I; Wesseling H
Effects of streptokinase during acute myocardial infarction on the signal-averaged electrocardiogram and on the frequency of late arrhythmias.
The American journal of cardiology 1993;72(9):647-51.
1993: Tuininga Y S; Crijns H J; Wiesfeld A C; Van Veldhuisen D J; Hillege H L; Lie K I
Electrocardiographic patterns relative to initiating mechanisms of exercise-induced ventricular tachycardia.
American heart journal 1993;126(2):359-67.
1993: Crijns H J; Kingma J H; Gosselink A T; Dalrymple H W; De Langen C D; Lie K
Sequential bilateral bundle branch block during dofetilide, a new class III antiarrhythmic agent, in a patient with atrial fibrillation.
Journal of cardiovascular electrophysiology 1993;4(4):459-66.
1993: van den Berg M P; Crijns H J; Gosselink A T; van den Broek S A; Hillege H J; van Veldhuisen D J; Lie K I
Chronotropic response to exercise in patients with atrial fibrillation: relation to functional state.
British heart journal 1993;70(2):150-3.
1993: van den Broek S A; van Veldhuisen D J; de Graeff P A; Crijns H J; van Gilst W H; Hillege H; Lie K I
Mode of death in patients with congestive heart failure: comparison between possible candidates for heart transplantation and patients with less advanced disease.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 1993;12(3):367-71.
1993: Crijns H J; Kingma J H; Gosselink A T; Lie K
Comparison in the same patient of aberrant conduction and bundle branch reentry after dofetilide, a new selective class III antiarrhythmic agent.
Pacing and clinical electrophysiology : PACE 1993;16(5 Pt 1):1006-16.
1993: Pentinga M L; Meeder J G; Crijns H J; de Muinck E D; Wiesfeld A C; Lie K I
Late onset atrioventricular nodal tachycardia.
International journal of cardiology 1993;38(3):293-8.
1993: Gosselink A T; Crijns H J; Wiesfeld A C; Lie K I
Exercise-induced ventricular tachycardia: a rare manifestation of digitalis toxicity.
Clinical cardiology 1993;16(3):270-2.
1993: Crijns H J; de Langen C D; Grandjean J G; Bel K J; Ebels T; Lie K I; Wesseling H
Sustained atrial flutter around the tricuspid valve in pigs: differentiation of procainamide (class IA) from flecainide (class IC) and their rate-dependent effects.
Journal of cardiovascular pharmacology 1993;21(3):462-70.
1993: Crijns H J; Oosterhuis B; Wiesfeld A C; De Bruin H; Mensink C K; Jonkman J H; Kozma C; Lie K I
Electrophysiologic and pharmacokinetic profile of the new antiarrhythmic drug TYB-3823 in humans.
Journal of cardiovascular pharmacology 1993;21(1):1-6.
1992: Wiesfeld A C; Crijns H J; Tobé T J; Almgren O; Bergstrand R H; Aberg J; Haaksma J; Lie K I
Electropharmacologic effects and pharmacokinetics of almokalant, a new class III antiarrhythmic, in patients with healed or healing myocardial infarcts and complex ventricular arrhythmias.
The American journal of cardiology 1992;70(11):990-6.
1992: Wiesfeld A C; Crijns H J; Van Veldhuisen D J; Van Gilst W H; Lie K I
Triggered activity as arrhythmogenic mechanism after myocardial infarction: clinical and electrophysiologic study of one case.
Clinical cardiology 1992;15(9):689-92.
1992: Gosselink A T; Crijns H J; Van Gelder I C; Hillige H; Wiesfeld A C; Lie K I
Low-dose amiodarone for maintenance of sinus rhythm after cardioversion of atrial fibrillation or flutter.
JAMA : the journal of the American Medical Association 1992;267(24):3289-93.
1991: Van Veldhuisen D J; Crijns H J; Girbes A R; Tobé T J; Wiesfeld A C; Lie K I
Electrophysiologic profile of ibopamine in patients with congestive heart failure and ventricular tachycardia and relation to its effects on hemodynamics and plasma catecholamines.
The American journal of cardiology 1991;68(11):1194-202.
1991: Crijns H J; Van Gelder I C; Van Gilst W H; Hillege H; Gosselink A M; Lie K I
Serial antiarrhythmic drug treatment to maintain sinus rhythm after electrical cardioversion for chronic atrial fibrillation or atrial flutter.
The American journal of cardiology 1991;68(4):335-41.
1991: Van Gelder I C; Crijns H J; Van Gilst W H; Verwer R; Lie K I
Prediction of uneventful cardioversion and maintenance of sinus rhythm from direct-current electrical cardioversion of chronic atrial fibrillation and flutter.
The American journal of cardiology 1991;68(1):41-6.
1991: Van Gelder I C; Crijns H J; Van Gilst W H; Hamer H P; Lie K I
Decrease of right and left atrial sizes after direct-current electrical cardioversion in chronic atrial fibrillation.
The American journal of cardiology 1991;67(1):93-5.
1991: Van Gelder I C; Crijns H J; Van der Laarse A; Van Gilst W H; Lie K I
Incidence and clinical significance of ST segment elevation after electrical cardioversion of atrial fibrillation and atrial flutter.
American heart journal 1991;121(1 Pt 1):51-6.
1991: Van Veldhuisen D J; Girbes A R; Crijns H J; Smit A J; Van Gilst W H; Lie K I
The oral dopamine agonist, ibopamine, in normal man: effects on rhythm, heart rate, blood pressure and catecholamines.
International journal of clinical pharmacology research 1991;11(3):159-65.
1990: van Wijk L M; Crijns H J; Kingma H J; van Gilst W H; van Gelder I C; Wesseling H; Lie K I
Flecainide: long-term effects in patients with sustained ventricular tachycardia or ventricular fibrillation.
Journal of cardiovascular pharmacology 1990;15(6):884-91.
1990: van der Linde M R; Crijns H J; de Koning J; Hoogkamp-Korstanje J A; de Graaf J J; Piers D A; van der Galiën A; Lie K I
Range of atrioventricular conduction disturbances in Lyme borreliosis: a report of four cases and review of other published reports.
British heart journal 1990;63(3):162-8.
1990: van Veldhuisen D J; Girbes A R; Crijns H J; Smit A J; de Graeff P A; Lie K I
Efficacy and safety of ibopamine in congestive heart failure.
Journal of autonomic pharmacology 1990;10 Suppl 1():s115-21.
1989: Van Gelder I C; Crijns H J; Van Gilst W H; Van Wijk L M; Hamer H P; Lie K I
Efficacy and safety of flecainide acetate in the maintenance of sinus rhythm after electrical cardioversion of chronic atrial fibrillation or atrial flutter.
The American journal of cardiology 1989;64(19):1317-21.
1989: den Heijer P; van Dijk R B; Crijns H J; Groeskamp J J; Lie K I
Coronary angioplasty using the probing catheter in combination with the Probe balloon wire.
The American journal of cardiology 1989;64(16):1041-3.
1989: van Wijk L M; van den Toren W E; van Gelder I; Crijns H J; Ruegg P; Lie K I
Electrophysiological properties of isradipine (PN200-110) in humans.
Journal of cardiovascular pharmacology 1989;14(3):492-5.
1989: van der Linde M R; Crijns H J; Lie K I
Transient complete AV block in Lyme disease. Electrophysiologic observations.
Chest 1989;96(1):219-21.
1989: de Koning J; Hoogkamp-Korstanje J A; van der Linde M R; Crijns H J
Demonstration of spirochetes in cardiac biopsies of patients with Lyme disease.
The Journal of infectious diseases 1989;160(1):150-3.
1989: van Wijk L M; van Gelder I; Crijns H J; van den Toren E W; Lie K I; Rüegg P C
Cardiac electrophysiologic properties of intravenous isradipine in patients with sick sinus syndrome.
The American journal of medicine 1989;86(4A):88-90.
1989: van Wijk L M; Crijns H J; van Gilst W H; Wesseling H; Lie K I
Flecainide acetate in the treatment of supraventricular tachycardias: value of programmed electrical stimulation for long-term prognosis.
American heart journal 1989;117(2):365-9.
1989: Van Gelder I C; Crijns H J; Van Gilst W H; De Langen C D; Van Wijk L M; Lie K I
Effects of flecainide on the atrial defibrillation threshold.
The American journal of cardiology 1989;63(1):112-4.
1989: van Wijk L M; den Heijer P; Crijns H J; van Gilst W H; Lie K I
Flecainide versus quinidine in the prevention of paroxysms of atrial fibrillation.
Journal of cardiovascular pharmacology 1989;13(1):32-6.
1988: Crijns H J; van Gelder I C; Lie K I
Supraventricular tachycardia mimicking ventricular tachycardia during flecainide treatment.
The American journal of cardiology 1988;62(17):1303-6.
1988: van Dijk R B; Lie K I; Crijns H J
Diltiazem in comparison with metoprolol in stable angina pectoris.
European heart journal 1988;9(11):1194-9.
1988: Crijns H J; van Wijk L M; van Gilst W H; Kingma J H; van Gelder I C; Lie K I
Acute conversion of atrial fibrillation to sinus rhythm: clinical efficacy of flecainide acetate. Comparison of two regimens.
European heart journal 1988;9(6):634-8.
1988: Crijns H J; den Heijer P; van Wijk L M; Lie K I
Successful use of flecainide in atrial fibrillation with rapid ventricular rate in the Wolff-Parkinson-White syndrome.
American heart journal 1988;115(6):1317-21.
1988: van Gelder I C; Crijns H J; van Wijk L M; van Gilst W H; Lie K I
Abnormal pharmacokinetics of flecainide in a "nonresponder".
Clinical cardiology 1988;11(5):353-5.
1987: den Heijer P; Crijns H J; Van Binsbergen E J; Ebels T; De Jongste M J; Lie K I
Orthodromic pacemaker circus movement tachycardia.
Pacing and clinical electrophysiology : PACE 1987;10(4 Pt 1):955-7.

Sign-in to see more